docid,section,sentenceid,subject_text,subject_type,object_text,object_type,relation
12368048,title,1,transplant tolerance,Organism Function,nonhuman primate,Mammal,PROCESS_OF
12641497,abstract,1,proton pump inhibitors,Pharmacologic Substance,rabeprazole,Pharmacologic Substance,COMPARED_WITH
12641497,abstract,1,therapies,Therapeutic or Preventive Procedure,rabeprazole,Pharmacologic Substance,USES
12868543,abstract,10,ranitidine,Pharmacologic Substance,drugs,Pharmacologic Substance,ISA
14534673,title,1,AIDS,Disease or Syndrome,tuberculosis,Disease or Syndrome,COEXISTS_WITH
14627806,abstract,9,alleles,Gene or Genome,cell lines,Cell,PART_OF
14627806,abstract,9,alleles,Gene or Genome,cell lines,Cell,PART_OF
14627806,abstract,9,mitomycin C,Antibiotic,alleles,Gene or Genome,AFFECTS
15323262,title,1,chronic renal disease,Disease or Syndrome,patients,Human,PROCESS_OF
15323262,abstract,9,secondary hyperparathyroidism,Disease or Syndrome,disorders,Disease or Syndrome,CAUSES
15323262,abstract,9,mineral metabolism impairment,Pathologic Function,secondary hyperparathyroidism,Disease or Syndrome,CAUSES
15323262,abstract,9,hypocalemia,Finding,mineral metabolism impairment,Pathologic Function,ISA
15323262,abstract,9,hypocalemia,Finding,secondary hyperparathyroidism,Disease or Syndrome,CAUSES
15473914,title,1,pramipexole,Organic Chemical,dopamine transporter,Gene or Genome,INHIBITS
15473914,title,1,pramipexole,Organic Chemical,D3 receptor,"Amino Acid, Peptide, or Protein",INTERACTS_WITH
15473914,title,1,Parkinson's disease,Disease or Syndrome,mouse,Mammal,PROCESS_OF
15473914,title,1,MPTP,Organic Chemical,mouse,Mammal,ADMINISTERED_TO
15473914,title,1,pramipexole,Organic Chemical,Parkinson's disease,Disease or Syndrome,PREVENTS
15499973,abstract,1,Meniere's disease,Disease or Syndrome,patients,Human,PROCESS_OF
15499973,abstract,1,dexamethasone injection,Clinical Drug,patients,Human,TREATS
15499973,abstract,1,dexamethasone injection,Clinical Drug,Meniere's disease,Disease or Syndrome,TREATS
15526143,abstract,2,neuroleptics,Pharmacologic Substance,BDNF,"Amino Acid, Peptide, or Protein",INHIBITS
15592935,title,1,nasal mucosa,Tissue,human,Human,PART_OF
15592935,title,1,allergic,Pathologic Function,human,Human,PROCESS_OF
15592935,title,1,nasal mucosa,Tissue,heme oxygenase,"Amino Acid, Peptide, or Protein",LOCATION_OF
15592935,abstract,10,respiratory epithelium,Tissue,HO-1,"Amino Acid, Peptide, or Protein",LOCATION_OF
15592935,abstract,10,respiratory epithelium,Tissue,nasal,"Body Part, Organ, or Organ Component",PART_OF
15592935,abstract,10,respiratory epithelium,Tissue,group,Human,PART_OF
15601558,abstract,6,brain,"Body Part, Organ, or Organ Component",single brain lesion,Finding,LOCATION_OF
15601558,abstract,6,Patients,Finding,single brain lesion,Human,PROCESS_OF
15601558,abstract,6,radiotherapy,Therapeutic or Preventive Procedure,Patients,Human,ADMINISTERED_TO
15601558,abstract,6,brain,"Body Part, Organ, or Organ Component",lesion,Finding,LOCATION_OF
15601558,abstract,6,WBRT,Therapeutic or Preventive Procedure,radiotherapy,Therapeutic or Preventive Procedure,PRECEDES
15601558,abstract,8,sequential treatments,Therapeutic or Preventive Procedure,neurological symptoms,Sign or Symptom,TREATS
15601558,abstract,8,neurological symptoms,Sign or Symptom,patients,Human,PROCESS_OF
15601558,abstract,13,Myelosuppression,Disease or Syndrome,toxicity,Injury or Poisoning,ISA
15601558,abstract,16,sequential treatments,Therapeutic or Preventive Procedure,patients,Human,TREATS
15601558,abstract,16,SCLC,Neoplastic Process,patients,Human,PROCESS_OF
15601558,abstract,16,brain metastases,Neoplastic Process,patients,Human,PROCESS_OF
15601558,abstract,16,brain metastases,Neoplastic Process,SCLC,Neoplastic Process,COEXISTS_WITH
15601558,abstract,16,sequential treatment,Therapeutic or Preventive Procedure,SCLC,Neoplastic Process,TREATS
15601558,abstract,16,sequential treatment,Therapeutic or Preventive Procedure,brain metastases,Neoplastic Process,TREATS
15601558,abstract,16,sequential treatment,Therapeutic or Preventive Procedure,neurological symptoms,Sign or Symptom,TREATS
15601558,abstract,16,sequential treatment,Therapeutic or Preventive Procedure,metastatic lesions,Finding,TREATS
15623373,abstract,2,Primary HCC,Neoplastic Process,patients,Human,PROCESS_OF
15623373,abstract,2,resection,Therapeutic or Preventive Procedure,patients,Human,TREATS
15623373,abstract,2,resection,Therapeutic or Preventive Procedure,Primary HCC,Neoplastic Process,TREATS
15623373,abstract,10,tissues,Tissue,cancer,Neoplastic Process,LOCATION_OF
15623373,abstract,10,tissues,Tissue,MMP-2,"Amino Acid, Peptide, or Protein",PRODUCES
15623373,abstract,10,tissues,Tissue,Ki-67,"Amino Acid, Peptide, or Protein",PRODUCES
15623373,abstract,10,tissues,Tissue,VEGF,"Amino Acid, Peptide, or Protein",PRODUCES
15623373,abstract,10,tissues,Tissue,c-Myc,"Amino Acid, Peptide, or Protein",PRODUCES
15623373,abstract,10,VEGF,"Amino Acid, Peptide, or Protein",tissues,Tissue,PART_OF
15623373,abstract,10,resection,Therapeutic or Preventive Procedure,tumor,Neoplastic Process,TREATS
15623373,abstract,10,resection,Therapeutic or Preventive Procedure,HCC,Neoplastic Process,PRECEDES
15623373,abstract,10,HCC,Neoplastic Process,their,Human,PROCESS_OF
15634358,title,1,genetics,Biologic Function,Caenorhabditis briggsae,Invertebrate,PROCESS_OF
15676161,abstract,2,Asymptomatic,Finding,patients,Human,PROCESS_OF
15676161,abstract,3,chest pain,Sign or Symptom,patients,Human,PROCESS_OF
15722357,abstract,3,bezafibrate,Pharmacologic Substance,I-FABP,"Amino Acid, Peptide, or Protein",INTERACTS_WITH
15722357,abstract,3,ibuprofen,Pharmacologic Substance,I-FABP,"Amino Acid, Peptide, or Protein",INTERACTS_WITH
15722357,abstract,3,nitrazepam,Pharmacologic Substance,I-FABP,"Amino Acid, Peptide, or Protein",INTERACTS_WITH
15722357,abstract,3,bezafibrate,Pharmacologic Substance,drugs,Pharmacologic Substance,ISA
15722357,abstract,3,ibuprofen,Pharmacologic Substance,drugs,Pharmacologic Substance,ISA
15722357,abstract,3,nitrazepam,Pharmacologic Substance,drugs,Pharmacologic Substance,ISA
15750263,abstract,1,FK-739,Organic Chemical,angiotensin II type 1 (AT1) receptor antagonist,Pharmacologic Substance,ISA
15750263,abstract,1,enalapril,Pharmacologic Substance,angiotensin-converting enzyme (ACE) inhibitor,Pharmacologic Substance,ISA
15750263,abstract,1,FK-739,Organic Chemical,enalapril,Pharmacologic Substance,COMPARED_WITH
15750263,abstract,1,arteries,"Body Part, Organ, or Organ Component",Wistar-Kyoto rats,Mammal,PART_OF
15750263,abstract,1,arteries,"Body Part, Organ, or Organ Component",spontaneously hypertensive rats,Mammal,PART_OF
15750263,abstract,1,arteries,"Body Part, Organ, or Organ Component",smooth muscle (SM) cell,Cell,LOCATION_OF
15750263,abstract,1,enalapril,Pharmacologic Substance,smooth muscle (SM) cell,Cell,AFFECTS
15750263,abstract,1,FK-739,Organic Chemical,smooth muscle (SM) cell,Cell,AFFECTS
15750284,abstract,5,GH,"Amino Acid, Peptide, or Protein",B-lymphoid precursors,Cell,AFFECTS
15750284,abstract,5,bone marrow stem cells,Cell,B-lymphoid precursors,Cell,LOCATION_OF
15750284,abstract,6,stem cells,Cell,mRNAs,Biologically Active Substance,LOCATION_OF
15750284,abstract,6,mRNAs,Biologically Active Substance,GH,"Amino Acid, Peptide, or Protein",PART_OF
15750284,abstract,6,mRNAs,Biologically Active Substance,GH receptor,"Amino Acid, Peptide, or Protein",PART_OF
15750284,abstract,6,stem cells,Cell,mRNAs,Biologically Active Substance,LOCATION_OF
15750284,abstract,6,B-cell precursors,Cell,bone marrow,"Body Part, Organ, or Organ Component",PART_OF
15750284,abstract,6,stem cells,Cell,bone marrow,"Body Part, Organ, or Organ Component",PART_OF
15750284,abstract,6,GH,"Amino Acid, Peptide, or Protein",B-lymphoid precursors,Cell,AFFECTS
15750284,abstract,6,bone marrows,"Body Part, Organ, or Organ Component",B-lymphoid precursors,Cell,LOCATION_OF
15763007,title,1,azoospermic,Disease or Syndrome,patients,Human,PROCESS_OF
15765262,title,1,Nicotine,Organic Chemical,conditioned place preferences,Mental Process,AUGMENTS
15765262,title,1,conditioned place preferences,Mental Process,rats,Mammal,PROCESS_OF
15776283,abstract,2,muscle,Tissue,IFN-gamma,"Amino Acid, Peptide, or Protein",LOCATION_OF
15776283,abstract,2,IFN-gamma,"Amino Acid, Peptide, or Protein",tumor,Neoplastic Process,PREDISPOSES
15776283,abstract,2,hepatoma,Neoplastic Process,tumor,Neoplastic Process,ISA
15776283,abstract,2,mammary adenocarcinoma,Neoplastic Process,tumor,Neoplastic Process,ISA
15776283,abstract,2,B16 melanoma,Neoplastic Process,tumor,Neoplastic Process,ISA
15776283,abstract,2,IFN-gamma,"Amino Acid, Peptide, or Protein",hepatoma,Neoplastic Process,PREDISPOSES
15776283,abstract,2,IFN-gamma,"Amino Acid, Peptide, or Protein",mammary adenocarcinoma,Neoplastic Process,PREDISPOSES
15776283,abstract,2,IFN-gamma,"Amino Acid, Peptide, or Protein",B16 melanoma,Neoplastic Process,PREDISPOSES
15790407,abstract,9,antibiotics,Antibiotic,interventions,Health Care Activity,ISA
15790407,abstract,9,steroids,Steroid,interventions,Health Care Activity,ISA
15790407,abstract,9,administration,Therapeutic or Preventive Procedure,interventions,Health Care Activity,ISA
15790407,abstract,9,therapies,Therapeutic or Preventive Procedure,intervention,Health Care Activity,ISA
15790407,abstract,9,therapies,Therapeutic or Preventive Procedure,mucolytic,Pharmacologic Substance,USES
15790407,abstract,9,exercise,Daily or Recreational Activity,interventions,Health Care Activity,ISA
15790407,abstract,9,antibiotics,Antibiotic,interventions,Health Care Activity,ISA
15790407,abstract,9,pancreatic enzymes,Pharmacologic Substance,interventions,Health Care Activity,ISA
15797093,abstract,1,right atrium,"Body Part, Organ, or Organ Component",infant,Human,PART_OF
15797093,abstract,1,right atrium,"Body Part, Organ, or Organ Component",epithelioid hemangioendothelioma,Neoplastic Process,LOCATION_OF
15808413,abstract,5,plasma,Body Substance,nitrate,Inorganic Chemical,LOCATION_OF
15808413,abstract,5,nitrite,Chemical Viewed Structurally,nitrate,Inorganic Chemical,CONVERTS_TO
15808413,abstract,6,plasma,Body Substance,NOx,Biologically Active Substance,LOCATION_OF
15818416,title,1,tBid,"Amino Acid, Peptide, or Protein",cardiolipin,Lipid,INTERACTS_WITH
15818416,title,1,mitochondrial,Cell Component,dysfunction,Pathologic Function,LOCATION_OF
15818416,abstract,1,mitochondria,Cell Component,tBid,"Amino Acid, Peptide, or Protein",LOCATION_OF
15818416,abstract,1,Bid,"Amino Acid, Peptide, or Protein",cytosolic,Cell Component,PART_OF
15818416,abstract,1,TNFR1,"Amino Acid, Peptide, or Protein",Fas,Gene or Genome,INTERACTS_WITH
15818416,abstract,6,mitochondria,Cell Component,yeast,Fungus,PART_OF
15818416,abstract,6,cardiolipin,Lipid,tBid,"Amino Acid, Peptide, or Protein",INTERACTS_WITH
15818416,abstract,6,tBid,"Amino Acid, Peptide, or Protein",respiratory,Cell Function,DISRUPTS
15818416,abstract,7,mitochondria,Cell Component,yeast,Fungus,PART_OF
15818416,abstract,7,ADP,Biologically Active Substance,respiration,Physiologic Function,AUGMENTS
15862965,abstract,4,calcitriol,Hormone,PDGF receptors,"Amino Acid, Peptide, or Protein",INTERACTS_WITH
15862965,abstract,4,calcitriol,Hormone,cell growth,Cell Function,AFFECTS
15862965,abstract,4,PDGF-BB,"Amino Acid, Peptide, or Protein",cell growth,Cell Function,AFFECTS
15862965,abstract,4,cells,Cell,prostate,"Body Part, Organ, or Organ Component",PART_OF
15862965,abstract,4,cells,Cell,calcitriol,Steroid,LOCATION_OF
15866565,abstract,14,chemotherapeutic,Therapeutic or Preventive Procedure,primordial follicles,Embryonic Structure,DISRUPTS
15866565,abstract,14,GnRH agonists,Pharmacologic Substance,primordial follicles,Embryonic Structure,AFFECTS
15866565,abstract,14,cyclophosphamide,Pharmacologic Substance,ovary,"Body Part, Organ, or Organ Component",DISRUPTS
15866565,abstract,14,GnRH agonists,Pharmacologic Substance,ovary,"Body Part, Organ, or Organ Component",AFFECTS
15872117,abstract,10,NF-kappaB,"Amino Acid, Peptide, or Protein",DNA,Biologically Active Substance,INTERACTS_WITH
15872117,abstract,11,compounds,Chemical,p50,Gene or Genome,INTERACTS_WITH
15872117,abstract,11,compounds,Chemical,transcription factor,"Amino Acid, Peptide, or Protein",INTERACTS_WITH
15872117,abstract,11,compounds,Chemical,p65,Biologically Active Substance,INTERACTS_WITH
15877828,title,1,Extracorporeal shock wave lithotripsy,Therapeutic or Preventive Procedure,renal pelvicalyceal stones,Pathologic Function,TREATS
15877828,title,1,renal pelvicalyceal stones,Pathologic Function,patients,Human,PROCESS_OF
15877828,title,1,obese,Disease or Syndrome,patients,Human,PROCESS_OF
15877828,title,1,renal pelvicalyceal stones,Pathologic Function,obese,Disease or Syndrome,COEXISTS_WITH
15877828,abstract,2,obese,Disease or Syndrome,patients,Human,PROCESS_OF
15877828,abstract,2,non-obese,Disease or Syndrome,patients,Human,PROCESS_OF
15877828,abstract,11,pelvic stones,Disease or Syndrome,patients,Human,PROCESS_OF
15877828,abstract,11,treatment,Therapeutic or Preventive Procedure,patients,Human,TREATS
15877828,abstract,11,treatment,Therapeutic or Preventive Procedure,pelvic stones,Disease or Syndrome,TREATS
15877828,abstract,14,obese,Disease or Syndrome,patients,Human,PROCESS_OF
15877828,abstract,14,pelvic stones,Disease or Syndrome,patients,Human,PROCESS_OF
15877828,abstract,14,ESWL,Therapeutic or Preventive Procedure,patients,Human,TREATS
15877828,abstract,14,ESWL,Therapeutic or Preventive Procedure,pelvic stones,Disease or Syndrome,TREATS
15877828,abstract,17,ESWL,Therapeutic or Preventive Procedure,patients,Human,TREATS
15877828,abstract,17,obese,Disease or Syndrome,patients,Human,PROCESS_OF
15877828,abstract,17,caliceal stones,Disease or Syndrome,patients,Human,PROCESS_OF
15877828,abstract,17,ESWL,Therapeutic or Preventive Procedure,caliceal stones,Disease or Syndrome,TREATS
15885340,abstract,2,neck,Body Location or Region,tumor,Neoplastic Process,LOCATION_OF
15885340,abstract,2,tumor,Neoplastic Process,girl,Human,PROCESS_OF
15885340,abstract,2,tumor,Neoplastic Process,calcification,Pathologic Function,COEXISTS_WITH
15896365,abstract,1,Apyrase,"Amino Acid, Peptide, or Protein",nucleosides,"Nucleic Acid, Nucleoside, or Nucleotide",INTERACTS_WITH
15896365,abstract,1,ATP-diphosphohydrolase,"Amino Acid, Peptide, or Protein",ion,"Element, Ion, or Isotope",COEXISTS_WITH
15896365,abstract,8,nucleotide,"Nucleic Acid, Nucleoside, or Nucleotide",inactivation,Cell or Molecular Dysfunction,CAUSES
15896365,abstract,8,potato,Plant,apyrase,"Amino Acid, Peptide, or Protein",LOCATION_OF
15898907,title,1,Laparoscopic surgery,Therapeutic or Preventive Procedure,obstruction of the gastric outlet,Disease or Syndrome,TREATS
15898907,title,1,Laparoscopic surgery,Therapeutic or Preventive Procedure,small bowel,Disease or Syndrome,TREATS
15898907,title,1,laparotomy,Therapeutic or Preventive Procedure,Laparoscopic surgery,Therapeutic or Preventive Procedure,PRECEDES
15898907,title,1,laparotomy,Therapeutic or Preventive Procedure,palliation,Finding,TREATS
15898907,title,1,upper gastrointestinal,Body System,resection,Therapeutic or Preventive Procedure,LOCATION_OF
15898907,title,1,laparotomy,Therapeutic or Preventive Procedure,resection,Therapeutic or Preventive Procedure,METHOD_OF
15898907,abstract,1,Surgical,Therapeutic or Preventive Procedure,gastric outlet obstruction,Disease or Syndrome,TREATS
15898907,abstract,1,Surgical,Therapeutic or Preventive Procedure,small bowel obstruction,Disease or Syndrome,TREATS
15898907,abstract,1,small bowel obstruction,Disease or Syndrome,patients,Human,PROCESS_OF
15898907,abstract,1,gastric outlet obstruction,Disease or Syndrome,patients,Human,PROCESS_OF
15898907,abstract,1,bypass surgery,Therapeutic or Preventive Procedure,malignancy,Neoplastic Process,TREATS
15898907,abstract,1,resection,Therapeutic or Preventive Procedure,malignancy,Neoplastic Process,TREATS
15898907,abstract,1,bypass surgery,Therapeutic or Preventive Procedure,patients,Human,ADMINISTERED_TO
15898907,abstract,1,resection,Therapeutic or Preventive Procedure,patients,Human,ADMINISTERED_TO
15898907,abstract,2,surgery,Therapeutic or Preventive Procedure,complications,Pathologic Function,TREATS
15912426,title,1,tumor,Neoplastic Process,rat,Mammal,PROCESS_OF
15912426,title,1,2-deoxy-2-[F-18]fluoro-D-glucose,Diagnostic Procedure,gamma camera imaging,"Indicator, Reagent, or Diagnostic Aid",USES
15912426,title,1,follow-up,Health Care Activity,gamma camera imaging,Diagnostic Procedure,USES
15912426,abstract,2,injection,Therapeutic or Preventive Procedure,FDG,Organic Chemical,USES
15912426,abstract,2,tumor,Neoplastic Process,animal tumor models,Animal,PROCESS_OF
15912426,abstract,2,osteosarcoma,Neoplastic Process,tumor,Neoplastic Process,ISA
15912426,abstract,2,melanoma,Neoplastic Process,tumor,Neoplastic Process,ISA
15912426,abstract,2,breast cancer,Neoplastic Process,tumor,Neoplastic Process,ISA
15912426,abstract,2,osteosarcoma,Neoplastic Process,animal tumor models,Animal,PROCESS_OF
15912426,abstract,2,melanoma,Neoplastic Process,animal tumor models,Animal,PROCESS_OF
15912426,abstract,2,breast cancer,Neoplastic Process,animal tumor models,Animal,PROCESS_OF
15913690,abstract,4,Histological evaluation,Laboratory Procedure,dermal hemorrhage,Disease or Syndrome,DIAGNOSES
15918623,title,1,soft tissue,Tissue,Malignant smooth muscle tumours,Neoplastic Process,LOCATION_OF
15918623,title,1,tertiary care hospital,Health Care Related Organization,study,Research Activity,LOCATION_OF
15918623,abstract,23,extremities,"Body Part, Organ, or Organ Component",LMS,Neoplastic Process,LOCATION_OF
15918623,abstract,23,trunk,"Body Part, Organ, or Organ Component",LMS,Neoplastic Process,LOCATION_OF
15918623,abstract,23,LMS,Neoplastic Process,females,Human,PROCESS_OF
15919667,abstract,3,UDP-Glc,Biologically Active Substance,proteoglycans,"Amino Acid, Peptide, or Protein",INTERACTS_WITH
15919667,abstract,3,UDP-Glc,Biologically Active Substance,glycoproteins,"Amino Acid, Peptide, or Protein",INTERACTS_WITH
15919667,abstract,3,UDP-Glc,Biologically Active Substance,glycosphingolipids,Lipid,INTERACTS_WITH
15919667,abstract,3,gly-coconjugates,Carbohydrate,PLC,"Amino Acid, Peptide, or Protein",INTERACTS_WITH
15919667,abstract,4,PLC,"Amino Acid, Peptide, or Protein",Cp,Bacterium,PART_OF
15919667,abstract,4,Cp-PLC,"Amino Acid, Peptide, or Protein",cell line,Cell,AFFECTS
15919667,abstract,4,gangliosides,Biologically Active Substance,cell line,Cell,PART_OF
15919667,abstract,6,C. perfringens,Bacterium,sialidase,"Amino Acid, Peptide, or Protein",LOCATION_OF
15919667,abstract,6,sialidase,"Amino Acid, Peptide, or Protein",sialic acids,Carbohydrate,INHIBITS
15919667,abstract,6,PLC,"Amino Acid, Peptide, or Protein",cultured cells,Cell,AFFECTS
15919667,abstract,6,sialidase,"Amino Acid, Peptide, or Protein",cultured cells,Cell,AFFECTS
15919667,abstract,6,C. perfringens,Bacterium,sialidase,"Amino Acid, Peptide, or Protein",LOCATION_OF
15919667,abstract,6,Cp,Bacterium,PLC,"Amino Acid, Peptide, or Protein",LOCATION_OF
15919667,abstract,6,Cp,Bacterium,PLC,"Amino Acid, Peptide, or Protein",LOCATION_OF
15919667,abstract,6,mice,Mammal,PLC,"Amino Acid, Peptide, or Protein",LOCATION_OF
15919838,abstract,3,serum,Body Substance,VAP-1,"Amino Acid, Peptide, or Protein",LOCATION_OF
15919838,abstract,3,obese,Disease or Syndrome,subjects,Human,PROCESS_OF
15919838,abstract,3,VAP-1,"Amino Acid, Peptide, or Protein",subjects,Human,PART_OF
15925552,title,1,plasma,Body Substance,quercetin,Organic Chemical,LOCATION_OF
15925552,title,1,urine,Body Substance,quercetin,Organic Chemical,LOCATION_OF
15925552,title,1,plasma,Body Substance,metabolites,Biologically Active Substance,LOCATION_OF
15925552,title,1,urine,Body Substance,metabolites,Biologically Active Substance,LOCATION_OF
15925552,title,1,plasma,Body Substance,human,Human,PART_OF
15925552,title,1,urine,Body Substance,human,Human,PART_OF
15927218,abstract,1,Neurocysticercosis,Disease or Syndrome,neurological disease,Disease or Syndrome,CAUSES
15927218,abstract,2,ELISA,Laboratory Procedure,glycoproteins,"Amino Acid, Peptide, or Protein",USES
15927218,abstract,2,immunoblotting,Laboratory Procedure,glycoproteins,"Amino Acid, Peptide, or Protein",USES
15927218,abstract,2,cysticercosis,Disease or Syndrome,human,Human,PROCESS_OF
15927218,abstract,2,ELISA,Laboratory Procedure,cysticercosis,Disease or Syndrome,DIAGNOSES
15927218,abstract,2,immunoblotting,Laboratory Procedure,cysticercosis,Disease or Syndrome,DIAGNOSES
15927218,abstract,2,isoelectric focusing,Laboratory Procedure,immunoblotting,Laboratory Procedure,METHOD_OF
15927218,abstract,2,isoelectric focusing,Laboratory Procedure,ELISA,Laboratory Procedure,METHOD_OF
15927218,abstract,3,NCC,Disease or Syndrome,inpatients,Human,PROCESS_OF
15927218,abstract,3,NCC,Disease or Syndrome,outpatients,Patient or Disabled Group,PROCESS_OF
15927218,abstract,3,City Hospital,Health Care Related Organization,inpatients,Human,LOCATION_OF
15927218,abstract,3,City Hospital,Health Care Related Organization,outpatients,Patient or Disabled Group,LOCATION_OF
15927218,abstract,3,Inner Mongolia,Geographic Area,residents,Population Group,LOCATION_OF
15927218,abstract,8,cysticercosis,Disease or Syndrome,patients,Human,PROCESS_OF
15927218,abstract,8,ELISA,Laboratory Procedure,cysticercosis,Disease or Syndrome,DIAGNOSES
15927218,abstract,8,immunoblotting,Laboratory Procedure,cysticercosis,Disease or Syndrome,DIAGNOSES
15935823,abstract,3,benzene exposure,Finding,workers,Human,PROCESS_OF
15943571,abstract,1,HIV-1,Virus,viremia,Disease or Syndrome,CAUSES
15943571,abstract,1,T cell immunity,Organism Function,viremia,Disease or Syndrome,AFFECTS
15943571,abstract,1,poxvirus,Virus,T cell immunity,Organism Function,AUGMENTS
15943571,abstract,1,T cell immunity,Organism Function,primates,Mammal,PROCESS_OF
15943571,abstract,1,genes,Gene or Genome,HIV-1,Virus,PART_OF
15943571,abstract,1,genes,Gene or Genome,DNA,Biologically Active Substance,PART_OF
15943707,abstract,2,donors,Pharmacologic Substance,dexamethasone,Human,ADMINISTERED_TO
15943707,abstract,2,rHuG-CSF,Pharmacologic Substance,donors,Human,ADMINISTERED_TO
15946936,title,1,tetraspanins,"Amino Acid, Peptide, or Protein",cell surface,Cell Component,PART_OF
15946936,title,1,BAP31,Gene or Genome,tetraspanins,"Amino Acid, Peptide, or Protein",INTERACTS_WITH
15946936,title,1,integrin,"Amino Acid, Peptide, or Protein",cell survival,Cell Function,AFFECTS
15946936,title,1,BAP31,Gene or Genome,cell survival,Cell Function,AFFECTS
15946936,title,1,caspase cleavage product,"Amino Acid, Peptide, or Protein",cell survival,Cell Function,AFFECTS
15946936,title,1,caspase cleavage product,"Amino Acid, Peptide, or Protein",tetraspanins,"Amino Acid, Peptide, or Protein",INTERACTS_WITH
15946936,abstract,2,tetraspanins,"Amino Acid, Peptide, or Protein",cell surface,Cell Component,PART_OF
15946936,abstract,2,tetraspanins,"Amino Acid, Peptide, or Protein",CD9,"Amino Acid, Peptide, or Protein",ISA
15946936,abstract,2,tetraspanins,"Amino Acid, Peptide, or Protein",CD81,"Amino Acid, Peptide, or Protein",ISA
15946936,abstract,2,cells,Cell,mouse,Mammal,PART_OF
15946936,abstract,2,cells,Cell,Bap31 gene,Gene or Genome,LOCATION_OF
15946936,abstract,2,cell surface,Gene or Genome,CD9,Cell Component,PART_OF
15946936,abstract,2,cell surface,Gene or Genome,CD9,Cell Component,PART_OF
15948171,abstract,2,predictive genetic testing,Diagnostic Procedure,hereditary nonpolyposis colorectal carcinoma (HNPCC),Neoplastic Process,DIAGNOSES
15948171,abstract,2,hereditary nonpolyposis colorectal carcinoma (HNPCC),Neoplastic Process,cohort,Human,PROCESS_OF
15948171,abstract,2,predictive genetic testing,Diagnostic Procedure,screening,Health Care Activity,PRECEDES
15953327,abstract,13,Infective endocarditis,Disease or Syndrome,illness,Finding,ISA
15953327,abstract,13,illness,Finding,children,Human,PROCESS_OF
15953327,abstract,13,Infective endocarditis,Disease or Syndrome,children,Human,PROCESS_OF
15953529,title,1,mouse vestibular epithelia,Body Substance,vestibular,"Body Part, Organ, or Organ Component",PART_OF
15953529,title,1,cell-cell junctions,Body Space or Junction,mouse vestibular epithelia,Body Substance,PART_OF
15953529,title,1,treatment,Therapeutic or Preventive Procedure,aminoglycoside,Pharmacologic Substance,USES
15953529,abstract,7,epithelia,Tissue,vestibular,"Body Part, Organ, or Organ Component",PART_OF
15953529,abstract,7,vestibular,"Body Part, Organ, or Organ Component",mammalian,Mammal,PART_OF
15953529,abstract,7,epithelia,Tissue,cell proliferations,Cell Function,LOCATION_OF
15956296,abstract,12,brine,Inorganic Chemical,salt,Inorganic Chemical,INTERACTS_WITH
15958124,abstract,1,Guillain-Barre syndrome,Disease or Syndrome,immune-mediated disorders,Disease or Syndrome,ISA
15958124,abstract,1,CIDP,Disease or Syndrome,immune-mediated disorders,Disease or Syndrome,ISA
15958124,abstract,2,Infections,Disease or Syndrome,GBS,Disease or Syndrome,CAUSES
15958124,abstract,2,Infections,Disease or Syndrome,CIDP,Disease or Syndrome,AUGMENTS
15958928,abstract,1,headaches,Sign or Symptom,employees,Human,PROCESS_OF
15958928,abstract,1,vomiting,Sign or Symptom,employees,Human,PROCESS_OF
15958928,abstract,1,nausea,Sign or Symptom,employees,Human,PROCESS_OF
15958928,abstract,1,chemical poisoning,Injury or Poisoning,headaches,Sign or Symptom,CAUSES
15958928,abstract,1,chemical poisoning,Injury or Poisoning,vomiting,Sign or Symptom,CAUSES
15958928,abstract,1,chemical poisoning,Injury or Poisoning,nausea,Sign or Symptom,CAUSES
15969273,abstract,4,disabilities,Pathologic Function,children,Human,PROCESS_OF
15969273,abstract,4,performance,Individual Behavior,mothers,Human,PROCESS_OF
15972039,abstract,1,surgical treatment,Therapeutic or Preventive Procedure,Graves' disease,Disease or Syndrome,TREATS
15972039,abstract,1,Total thyroidectomy,Therapeutic or Preventive Procedure,patients,Human,TREATS
15972621,abstract,1,working memory,Mental Process,cognitive functions,Mental Process,ISA
15974085,abstract,3,hexylamine,Organic Chemical,amines,Organic Chemical,ISA
15974085,abstract,3,octylamine,Organic Chemical,amines,Organic Chemical,ISA
15975940,abstract,6,Chordin,"Amino Acid, Peptide, or Protein",signaling molecules,Biologically Active Substance,ISA
15975940,abstract,6,Noggin,Gene or Genome,signaling molecules,Biologically Active Substance,ISA
15975940,abstract,6,Xnr6,"Amino Acid, Peptide, or Protein",signaling molecules,Biologically Active Substance,ISA
15975940,abstract,6,Cerberus,"Amino Acid, Peptide, or Protein",signaling molecules,Biologically Active Substance,ISA
15980893,title,1,DNA,"Nucleic Acid, Nucleoside, or Nucleotide",Selenomonas ruminantium,Bacterium,PART_OF
15982867,title,1,hepatoblastoma,Neoplastic Process,tumours,Neoplastic Process,ISA
15982867,abstract,4,growth,Organism Function,hepatic tumours,Neoplastic Process,AFFECTS
15988072,abstract,5,antibiotic prophylaxis,Therapeutic or Preventive Procedure,infection,Disease or Syndrome,PREVENTS
15989002,abstract,6,CAPS,Disease or Syndrome,patients,Human,PROCESS_OF
15989002,abstract,6,CAPS,Disease or Syndrome,patients,Human,PROCESS_OF
15990320,abstract,1,Polyamines,Organic Chemical,nucleotides,"Nucleic Acid, Nucleoside, or Nucleotide",INTERACTS_WITH
15990320,abstract,1,Polyamines,Organic Chemical,proteins,"Amino Acid, Peptide, or Protein",INTERACTS_WITH
15990320,abstract,1,Polyamines,Biologically Active Substance,nucleotides,"Nucleic Acid, Nucleoside, or Nucleotide",INTERACTS_WITH
15990320,abstract,1,Polyamines,Biologically Active Substance,proteins,"Amino Acid, Peptide, or Protein",INTERACTS_WITH
15993885,abstract,7,CRP,"Amino Acid, Peptide, or Protein",acute-phase proteins,"Amino Acid, Peptide, or Protein",ISA
15993885,abstract,7,SAA,"Amino Acid, Peptide, or Protein",acute-phase proteins,"Amino Acid, Peptide, or Protein",ISA
15993885,abstract,7,FIB,"Amino Acid, Peptide, or Protein",acute-phase proteins,"Amino Acid, Peptide, or Protein",ISA
15993962,abstract,1,implantation,Therapeutic or Preventive Procedure,restenosis,Acquired Abnormality,PRECEDES
15993962,abstract,1,SES,Therapeutic or Preventive Procedure,implantation,Pharmacologic Substance,USES
15993962,abstract,1,implantation,Therapeutic or Preventive Procedure,restenosis,Acquired Abnormality,TREATS
15993962,abstract,1,SES,Pharmacologic Substance,restenosis,Acquired Abnormality,TREATS
15993962,abstract,6,cardiac event,Disease or Syndrome,patients,Human,PROCESS_OF
15993962,abstract,6,dialysis status,Finding,cardiac event,Disease or Syndrome,AFFECTS
15993962,abstract,6,ejection fraction,Finding,cardiac event,Disease or Syndrome,AFFECTS
15993962,abstract,6,revascularization,Therapeutic or Preventive Procedure,cardiac event,Disease or Syndrome,AFFECTS
15993962,abstract,6,revascularization,Therapeutic or Preventive Procedure,SES,Pharmacologic Substance,USES
15993989,abstract,14,mice,Mammal,Sera,Body Substance,LOCATION_OF
15996060,title,1,rheumatoid arthritis,Disease or Syndrome,patients,Human,PROCESS_OF
15996060,title,1,Sex hormone,Hormone,patients,Human,PART_OF
15996060,abstract,2,women,Disease or Syndrome,RA,Human,PROCESS_OF
15996060,abstract,2,estrogens,Hormone,women,Human,PART_OF
15996060,abstract,7,patients,Human,DHEAS,Steroid,LOCATION_OF
15996060,abstract,7,patients,Human,free testosterone,Steroid,LOCATION_OF
15996060,abstract,7,patients,Human,DHEAS,Steroid,LOCATION_OF
15996060,abstract,7,patients,Human,free testosterone,Steroid,LOCATION_OF
15996060,abstract,10,RA,Disease or Syndrome,patients,Human,PROCESS_OF
15996060,abstract,10,anti-TNF,"Amino Acid, Peptide, or Protein",sex hormones,Hormone,INTERACTS_WITH
15996060,abstract,10,sex hormones,Human,patients,Hormone,LOCATION_OF
15996060,abstract,11,RA,Disease or Syndrome,patients,Human,PROCESS_OF
15998787,abstract,3,allergen,Immunologic Factor,inflammation,Pathologic Function,CAUSES
15998787,abstract,3,airway,"Body Part, Organ, or Organ Component",inflammation,Pathologic Function,LOCATION_OF
15998787,abstract,3,inflammation,Pathologic Function,mice,Mammal,PROCESS_OF
15998787,abstract,3,Nrf2,Gene or Genome,inflammation,Pathologic Function,AFFECTS
15998787,abstract,4,response,Clinical Attribute,mucus cell hyperplasia,Sign or Symptom,ASSOCIATED_WITH
15998787,abstract,4,asthmatic,Disease or Syndrome,mice,Mammal,PROCESS_OF
15998787,abstract,4,response,Clinical Attribute,mice,Mammal,PROCESS_OF
15998787,abstract,4,lungs,"Body Part, Organ, or Organ Component",infiltration of eosinophils,Pathologic Function,LOCATION_OF
15998787,abstract,4,response,Clinical Attribute,infiltration of eosinophils,Pathologic Function,ASSOCIATED_WITH
15998787,abstract,5,splenocytes,Cell,IL-13,"Amino Acid, Peptide, or Protein",LOCATION_OF
15998787,abstract,5,splenocytes,Cell,interleukin (IL)-4,"Amino Acid, Peptide, or Protein",LOCATION_OF
15998787,abstract,5,bronchoalveolar lavage fluid,Body Substance,IL-13,"Amino Acid, Peptide, or Protein",LOCATION_OF
15998787,abstract,5,bronchoalveolar lavage fluid,Body Substance,interleukin (IL)-4,"Amino Acid, Peptide, or Protein",LOCATION_OF
15998787,abstract,5,interleukin (IL)-4,"Amino Acid, Peptide, or Protein",cytokine,"Amino Acid, Peptide, or Protein",ISA
15998787,abstract,5,IL-13,"Amino Acid, Peptide, or Protein",cytokine,"Amino Acid, Peptide, or Protein",ISA
16000282,abstract,10,18F-FDG PET,Diagnostic Procedure,metastases,Neoplastic Process,DIAGNOSES
16000282,abstract,10,CT/MRI,Diagnostic Procedure,metastases,Neoplastic Process,DIAGNOSES
16012316,abstract,8,NSIP,Disease or Syndrome,patients,Human,PROCESS_OF
16012316,abstract,8,UIP,Disease or Syndrome,patients,Human,PROCESS_OF
16015001,abstract,5,serum,Body Substance,phosphorus,Pharmacologic Substance,LOCATION_OF
16015001,abstract,5,Patients,Human,phosphorus,Pharmacologic Substance,LOCATION_OF
16015001,abstract,5,Patients,Human,P,Pharmacologic Substance,LOCATION_OF
16020163,abstract,2,suicide,Injury or Poisoning,Black,Human,PROCESS_OF
16020163,abstract,2,men,Human,adult,Human,ISA
16020163,abstract,2,women,Human,adult,Human,ISA
16020163,abstract,2,acculturation,Social Behavior,suicide,Injury or Poisoning,AFFECTS
16024249,abstract,1,Fasciolosis,Disease or Syndrome,disease,Disease or Syndrome,ISA
16024249,abstract,1,breast,"Body Part, Organ, or Organ Component",parasitic infections,Disease or Syndrome,LOCATION_OF
16025281,abstract,6,BAFF-R,Gene or Genome,B-cell lymphoma,Neoplastic Process,PART_OF
16025281,abstract,6,B-lymphoblastic lymphoma,Neoplastic Process,B-cell lymphoma,Neoplastic Process,ISA
16025281,abstract,6,B-chronic lymphocytic leukemia/small lymphocytic lymphoma,Neoplastic Process,B-cell lymphoma,Neoplastic Process,ISA
16025281,abstract,6,mantle cell lymphoma,Neoplastic Process,B-cell lymphoma,Neoplastic Process,ISA
16025281,abstract,6,follicular lymphoma,Neoplastic Process,B-cell lymphoma,Neoplastic Process,ISA
16025281,abstract,6,diffuse large B-cell lymphoma,Neoplastic Process,B-cell lymphoma,Neoplastic Process,ISA
16025281,abstract,6,marginal zone B-cell lymphoma,Neoplastic Process,B-cell lymphoma,Neoplastic Process,ISA
16025281,abstract,6,lymphoplasmacytic lymphoma,Neoplastic Process,B-cell lymphoma,Neoplastic Process,ISA
16025281,abstract,6,plasma cell myeloma,Neoplastic Process,B-cell lymphoma,Neoplastic Process,ISA
16025281,abstract,6,Burkitt lymphoma,Neoplastic Process,B-cell lymphoma,Neoplastic Process,ISA
16025281,abstract,6,Hodgkin lymphoma,Neoplastic Process,B-cell lymphoma,Neoplastic Process,ISA
16025281,abstract,6,BAFF-R,Gene or Genome,B-lymphoblastic lymphoma,Neoplastic Process,PART_OF
16025281,abstract,6,BAFF-R,Gene or Genome,B-chronic lymphocytic leukemia/small lymphocytic lymphoma,Neoplastic Process,PART_OF
16025281,abstract,6,BAFF-R,Gene or Genome,mantle cell lymphoma,Neoplastic Process,PART_OF
16025281,abstract,6,BAFF-R,Gene or Genome,follicular lymphoma,Neoplastic Process,PART_OF
16025281,abstract,6,BAFF-R,Gene or Genome,diffuse large B-cell lymphoma,Neoplastic Process,PART_OF
16025281,abstract,6,BAFF-R,Gene or Genome,marginal zone B-cell lymphoma,Neoplastic Process,PART_OF
16025281,abstract,6,BAFF-R,Gene or Genome,lymphoplasmacytic lymphoma,Neoplastic Process,PART_OF
16025281,abstract,6,BAFF-R,Gene or Genome,plasma cell myeloma,Neoplastic Process,PART_OF
16025281,abstract,6,BAFF-R,Gene or Genome,Burkitt lymphoma,Neoplastic Process,PART_OF
16025281,abstract,6,BAFF-R,Gene or Genome,Hodgkin lymphoma,Neoplastic Process,PART_OF
16025281,abstract,7,BAFF-R,Gene or Genome,B-cell neoplasms,Neoplastic Process,PART_OF
16025281,abstract,7,BAFF-R,Gene or Genome,DLBCL,Neoplastic Process,PART_OF
16025281,abstract,7,BAFF-R,Gene or Genome,proliferation,Cell Function,AFFECTS
16025281,abstract,7,proliferation,Cell Function,lymphoid cells,Cell,AFFECTS
16025281,abstract,7,lymphoid cells,Cell,neoplastic,Neoplastic Process,LOCATION_OF
16030174,abstract,5,PCOS,Disease or Syndrome,women,Human,PROCESS_OF
16030174,abstract,11,follicular fluid,Body Substance,women,Human,PART_OF
16030174,abstract,11,PCOS,Disease or Syndrome,women,Human,PROCESS_OF
16030174,abstract,11,follicular fluid,Body Substance,inhibin B,"Amino Acid, Peptide, or Protein",LOCATION_OF
16030174,abstract,11,follicular fluid,Body Substance,inhibin A,"Amino Acid, Peptide, or Protein",LOCATION_OF
16038840,abstract,7,diverticular disease,Disease or Syndrome,patients,Human,PROCESS_OF
16038840,abstract,7,NSAID,Pharmacologic Substance,diverticular infection,Disease or Syndrome,PREDISPOSES
16038840,abstract,7,diverticular,Anatomical Abnormality,infection,Disease or Syndrome,LOCATION_OF
16038840,abstract,7,NSAID,Pharmacologic Substance,diverticular infection and perforation,Disease or Syndrome,PREDISPOSES
16044089,abstract,2,peritoneal lavage,Therapeutic or Preventive Procedure,oxygenated PFC,Pharmacologic Substance,USES
16044089,abstract,2,peritoneal lavage,Therapeutic or Preventive Procedure,hemorrhagic shock,Pathologic Function,TREATS
16044089,abstract,2,oxygenated PFC (O2-PFC),Pharmacologic Substance,hemorrhagic shock,Pathologic Function,TREATS
16044089,abstract,12,lavage,Therapeutic or Preventive Procedure,metabolic acidosis,Pathologic Function,TREATS
16044089,abstract,12,lavage,Therapeutic or Preventive Procedure,O2-PFC,Pharmacologic Substance,USES
16044089,abstract,12,O2-PFC,Pharmacologic Substance,metabolic acidosis,Pathologic Function,TREATS
16044089,abstract,12,O2-PFC,Pharmacologic Substance,damage,Injury or Poisoning,TREATS
16044089,abstract,12,intestinal,"Body Part, Organ, or Organ Component",damage,Injury or Poisoning,LOCATION_OF
16044089,abstract,12,HS/R,Pathologic Function,metabolic acidosis,Pathologic Function,CAUSES
16046858,abstract,4,injection,Therapeutic or Preventive Procedure,AMPA,Pharmacologic Substance,USES
16046858,abstract,4,injection,Therapeutic or Preventive Procedure,rats,Mammal,TREATS
16046858,abstract,4,AMPA,Pharmacologic Substance,rats,Mammal,ADMINISTERED_TO
16046858,abstract,4,white matter,Tissue,injury,Injury or Poisoning,LOCATION_OF
16046858,abstract,4,gray and white matter,Tissue,injury,Injury or Poisoning,LOCATION_OF
16046858,abstract,4,injection,Therapeutic or Preventive Procedure,injury,Injury or Poisoning,CAUSES
16046858,abstract,4,AMPA,Pharmacologic Substance,injury,Injury or Poisoning,CAUSES
16078061,abstract,2,surgery,Therapeutic or Preventive Procedure,epilepsy,Disease or Syndrome,TREATS
16078061,abstract,2,PET scan,Diagnostic Procedure,FDG,"Indicator, Reagent, or Diagnostic Aid",USES
16078061,abstract,7,FDG PET,Diagnostic Procedure,clinical management,Health Care Activity,AFFECTS
16078061,abstract,7,clinical management,Health Care Activity,patients,Human,TREATS
16079122,abstract,1,chronic lymphocytic leukemia,Neoplastic Process,patients,Human,AFFECTS
16079122,abstract,1,febrile,Finding,patients,Human,PROCESS_OF
16079122,abstract,2,febrile,Finding,patients,Human,PROCESS_OF
16079931,abstract,3,Doppler echocardiography,Diagnostic Procedure,left ventricular diastolic dysfunction,Disease or Syndrome,DIAGNOSES
16080004,abstract,8,safrole,Hazardous or Poisonous Substance,cell proliferation,Cell Function,AFFECTS
16080004,abstract,8,safrole,Organic Chemical,cell proliferation,Cell Function,AUGMENTS
16083305,title,1,Escherichia coli,Bacterium,BAFF,"Amino Acid, Peptide, or Protein",LOCATION_OF
16083305,title,1,mice,Mammal,NK cells,Cell,LOCATION_OF
16083305,title,1,mice,Mammal,CD8+ T lymphocytes,Cell,LOCATION_OF
16083305,title,1,mice,Mammal,CD4+,Cell,LOCATION_OF
16083305,title,1,BAFF,"Amino Acid, Peptide, or Protein",CD8+ T lymphocytes,Cell,AFFECTS
16083305,title,1,BAFF,"Amino Acid, Peptide, or Protein",CD4+,Cell,AFFECTS
16083305,title,1,BAFF,"Amino Acid, Peptide, or Protein",NK cells,Cell,AFFECTS
16083305,abstract,3,mice,Mammal,natural killer (NK) cells,Cell,LOCATION_OF
16083305,abstract,3,mice,Mammal,CD8(+) T lymphocytes,Cell,LOCATION_OF
16083305,abstract,3,mice,Mammal,CD4(+),Cell,LOCATION_OF
16083305,abstract,3,mice,Mammal,B lymphocytes,Cell,LOCATION_OF
16083305,abstract,3,B lymphocytes,Cell,splenic,"Body Part, Organ, or Organ Component",PART_OF
16083305,abstract,3,hsBAFF,"Amino Acid, Peptide, or Protein",B lymphocytes,Cell,AFFECTS
16083305,abstract,3,hsBAFF,"Amino Acid, Peptide, or Protein",CD4(+),Cell,AFFECTS
16083305,abstract,3,hsBAFF,"Amino Acid, Peptide, or Protein",CD8(+) T lymphocytes,Cell,AFFECTS
16083305,abstract,3,hsBAFF,"Amino Acid, Peptide, or Protein",natural killer (NK) cells,Cell,AFFECTS
16084063,title,1,beta-catenin,"Amino Acid, Peptide, or Protein",apoptosis,Cell Function,DISRUPTS
16084063,title,1,beta-catenin,"Amino Acid, Peptide, or Protein",invasive growth,Pathologic Function,AUGMENTS
16084063,title,1,invasive growth,Pathologic Function,HNSCC,Neoplastic Process,COEXISTS_WITH
16084063,abstract,1,Wnt/beta-catenin signaling pathway,"Amino Acid, Peptide, or Protein",cell proliferation,Cell Function,AFFECTS
16084063,abstract,1,Wnt/beta-catenin signaling pathway,"Amino Acid, Peptide, or Protein",oncogenesis,Neoplastic Process,AFFECTS
16091875,abstract,14,therapy,Therapeutic or Preventive Procedure,valganciclovir,Pharmacologic Substance,USES
16091875,abstract,14,therapy,Therapeutic or Preventive Procedure,CMV infections,Disease or Syndrome,TREATS
16091875,abstract,14,valganciclovir,Pharmacologic Substance,CMV infections,Disease or Syndrome,TREATS
16091875,abstract,14,PCR,Laboratory Procedure,CMV infections,Disease or Syndrome,DIAGNOSES
16091875,abstract,14,lung transplantation,Therapeutic or Preventive Procedure,bronchoalveolar lavage,Therapeutic or Preventive Procedure,PRECEDES
16100526,abstract,2,Veratridine,Biologically Active Substance,secretion,Biologic Function,CAUSES
16100526,abstract,2,Veratridine,Biologically Active Substance,neurons,Cell,AFFECTS
16100526,abstract,2,colon mucosa,"Body Part, Organ, or Organ Component",secretion,Biologic Function,LOCATION_OF
16100526,abstract,2,colon mucosa,"Body Part, Organ, or Organ Component",mouse,Mammal,PART_OF
16100526,abstract,12,NPY,"Amino Acid, Peptide, or Protein",neurotransmission,Cell Function,DISRUPTS
16100526,abstract,12,NPY,"Amino Acid, Peptide, or Protein",Y(2) receptors,"Amino Acid, Peptide, or Protein",STIMULATES
16100526,abstract,12,neurons,Cell,Y(2) receptors,"Amino Acid, Peptide, or Protein",LOCATION_OF
16100526,abstract,12,neurons,Cell,submucosal,Tissue,PART_OF
16100526,abstract,12,veratridine,Pharmacologic Substance,tissue,Tissue,AFFECTS
16101536,abstract,7,anti-cytokine biologics therapy,Therapeutic or Preventive Procedure,rheumatoid arthritis,Disease or Syndrome,TREATS
16101536,abstract,8,T cells,Cell,adhesion molecules,"Amino Acid, Peptide, or Protein",LOCATION_OF
16102747,abstract,6,MPEP,Pharmacologic Substance,mGlu5 receptor antagonist,Pharmacologic Substance,ISA
16102747,abstract,6,mGlu5 receptor antagonist,Pharmacologic Substance,sphincter relaxation,Organ or Tissue Function,DISRUPTS
16102747,abstract,6,esophageal,"Body Part, Organ, or Organ Component",sphincter relaxation,Organ or Tissue Function,LOCATION_OF
16102747,abstract,6,MPEP,Pharmacologic Substance,sphincter relaxation,Organ or Tissue Function,DISRUPTS
16102747,abstract,6,mGlu5 receptor,"Amino Acid, Peptide, or Protein",gastroesophageal reflux disease,Disease or Syndrome,TREATS
16105135,title,1,non-alcoholic fatty liver,Disease or Syndrome,disease,Disease or Syndrome,ISA
16105135,title,1,steatohepatitis,Disease or Syndrome,patients,Human,PROCESS_OF
16105135,title,1,disease,Disease or Syndrome,patients,Human,PROCESS_OF
16105135,title,1,non-alcoholic fatty liver,Disease or Syndrome,patients,Human,PROCESS_OF
16105135,title,1,homocysteine,"Amino Acid, Peptide, or Protein",steatohepatitis,Disease or Syndrome,PREDISPOSES
16105135,abstract,1,non-alcoholic fatty liver,Disease or Syndrome,disease,Disease or Syndrome,ISA
16105135,abstract,1,disease,Disease or Syndrome,patients,Human,PROCESS_OF
16105135,abstract,1,non-alcoholic fatty liver,Disease or Syndrome,patients,Human,PROCESS_OF
16105135,abstract,1,steatosis,Pathologic Function,patients,Human,PROCESS_OF
16105135,abstract,1,hyperhomocysteinemia,Disease or Syndrome,patients,Human,PROCESS_OF
16105135,abstract,1,cystathionine beta-synthase,"Amino Acid, Peptide, or Protein",hyperhomocysteinemia,Disease or Syndrome,CAUSES
16105135,abstract,1,homocysteine,"Amino Acid, Peptide, or Protein",patients,Human,PART_OF
16105135,abstract,11,non-alcoholic fatty liver,Disease or Syndrome,disease,Disease or Syndrome,ISA
16105135,abstract,11,patients,Human,homocysteine,"Amino Acid, Peptide, or Protein",LOCATION_OF
16105135,abstract,11,disease,Disease or Syndrome,patients,Human,PROCESS_OF
16105135,abstract,11,non-alcoholic fatty liver,Disease or Syndrome,patients,Human,PROCESS_OF
16109976,abstract,2,interleukin 1,"Amino Acid, Peptide, or Protein",lung inflammation,Disease or Syndrome,CAUSES
16109976,abstract,2,endotoxin,Carbohydrate,lung inflammation,Disease or Syndrome,CAUSES
16109976,abstract,2,lung inflammation,Disease or Syndrome,lambs,Mammal,PROCESS_OF
16109976,abstract,2,maturation,Physiologic Function,lambs,Mammal,PROCESS_OF
16109976,abstract,2,maturation,Physiologic Function,lung,"Body Part, Organ, or Organ Component",AFFECTS
16109976,abstract,2,lung inflammation,Disease or Syndrome,maturation,Physiologic Function,PRECEDES
16109976,abstract,4,injection,Therapeutic or Preventive Procedure,Lung inflammation,Disease or Syndrome,CAUSES
16109976,abstract,4,injection,Therapeutic or Preventive Procedure,endotoxin,Carbohydrate,USES
16109976,abstract,4,injection,Therapeutic or Preventive Procedure,IL-1,"Amino Acid, Peptide, or Protein",USES
16119618,abstract,2,Down syndrome,Congenital Abnormality,patients,Human,PROCESS_OF
16119618,abstract,2,EEG,Diagnostic Procedure,patients,Human,ADMINISTERED_TO
16119618,abstract,2,EEG,Diagnostic Procedure,children,Human,ADMINISTERED_TO
16126188,abstract,2,detection,Therapeutic or Preventive Procedure,detection,Therapeutic or Preventive Procedure,METHOD_OF
16126188,abstract,4,plasma,Body Substance,maternal,Human,PART_OF
16126188,abstract,4,plasma,Body Substance,DNA,Biologically Active Substance,LOCATION_OF
16126188,abstract,4,detection,Therapeutic or Preventive Procedure,fetal diseases,Disease or Syndrome,DIAGNOSES
16126188,abstract,4,detection,Therapeutic or Preventive Procedure,pregnancy-associated complications,Disease or Syndrome,DIAGNOSES
16126188,abstract,4,DNA,Biologically Active Substance,fetal,Embryonic Structure,PART_OF
16138263,abstract,5,L-thyroxin,"Amino Acid, Peptide, or Protein",Wistar rats,Mammal,TREATS
16141404,abstract,6,SFLLRN,"Amino Acid, Peptide, or Protein",EPC,Cell,AUGMENTS
16141404,abstract,6,SFLLRN,"Amino Acid, Peptide, or Protein",receptor CXCR-4,Receptor,STIMULATES
16141404,abstract,6,SFLLRN,"Amino Acid, Peptide, or Protein",SDF-1,"Amino Acid, Peptide, or Protein",STIMULATES
16141404,abstract,8,SFLLRN,"Amino Acid, Peptide, or Protein",PAR-1,Gene or Genome,STIMULATES
16141404,abstract,9,EPCs,Cell,PAR-1,"Amino Acid, Peptide, or Protein",PRODUCES
16141404,abstract,9,EPCs,Cell,Human,Human,PART_OF
16144778,abstract,8,anandamide,Biologically Active Substance,respiratory depression,Pathologic Function,CAUSES
16146326,abstract,1,hemiplegia,Sign or Symptom,subjects,Human,PROCESS_OF
16149149,title,1,collagen-induced arthritis,Experimental Model of Disease,mice,Mammal,PROCESS_OF
16149149,title,1,enteric mucosal immune,Organ or Tissue Function,mice,Mammal,PROCESS_OF
16149149,title,1,Gui Zhi decoction,Biologically Active Substance,enteric mucosal immune,Organ or Tissue Function,AFFECTS
16154523,title,1,hair specimens,"Body Part, Organ, or Organ Component",amphetamine,Organic Chemical,LOCATION_OF
16154523,title,1,hair specimens,"Body Part, Organ, or Organ Component",congeners,Chemical Viewed Structurally,LOCATION_OF
16154523,abstract,7,hair,"Body Part, Organ, or Organ Component",MDEA,Organic Chemical,LOCATION_OF
16154523,abstract,7,hair,"Body Part, Organ, or Organ Component",MDMA,Organic Chemical,LOCATION_OF
16154523,abstract,7,hair,"Body Part, Organ, or Organ Component",AM,Organic Chemical,LOCATION_OF
16154523,abstract,7,hair,"Body Part, Organ, or Organ Component",MA,Organic Chemical,LOCATION_OF
16154523,abstract,7,hair,"Body Part, Organ, or Organ Component",MDA,Organic Chemical,LOCATION_OF
16154523,abstract,7,hair,"Body Part, Organ, or Organ Component",abusers,Human,PART_OF
16160007,title,1,missense mutation,Genetic Function,ADAMTS13,Gene or Genome,AFFECTS
16160007,title,1,polymorphisms,Genetic Function,ADAMTS13,Gene or Genome,AFFECTS
16160007,title,1,polymorphisms,Genetic Function,amino acid,"Amino Acid, Peptide, or Protein",AFFECTS
16160007,abstract,1,thrombotic thrombocytopenic purpura,Disease or Syndrome,patients,Human,PROCESS_OF
16160007,abstract,1,ADAMTS13,Gene or Genome,patients,Human,PART_OF
16160007,abstract,1,Sequence analysis,Laboratory Procedure,rare missense mutation (R1336W),Cell or Molecular Dysfunction,DIAGNOSES
16160855,abstract,2,cutting,Therapeutic or Preventive Procedure,Denervation,Therapeutic or Preventive Procedure,METHOD_OF
16167756,abstract,8,SS,Disease or Syndrome,disease,Disease or Syndrome,ISA
16167981,abstract,2,chromosome 25 (ECA25),Cell Component,horse,Mammal,PART_OF
16167981,abstract,2,locus,Gene or Genome,horse chromosome 25 (ECA25),Cell Component,PART_OF
16172203,abstract,1,antipsychotic drugs,Pharmacologic Substance,agents,Chemical Viewed Functionally,COMPARED_WITH
16172797,title,1,High grade primary breast lymphoma,Neoplastic Process,breast,"Body Part, Organ, or Organ Component",PART_OF
16172797,abstract,1,lymphoma,Neoplastic Process,neoplasm,Neoplastic Process,ISA
16172797,abstract,1,lymphoma,Neoplastic Process,breast,"Body Part, Organ, or Organ Component",PART_OF
16176149,abstract,9,Ca deficiency,Disease or Syndrome,bone loss,Pathologic Function,CAUSES
16176149,abstract,9,OVX,Therapeutic or Preventive Procedure,bone loss,Pathologic Function,CAUSES
16176149,abstract,9,Ca deficiency,Disease or Syndrome,rats,Mammal,PROCESS_OF
16176149,abstract,9,OVX,Therapeutic or Preventive Procedure,rats,Mammal,ADMINISTERED_TO
16176149,abstract,9,extract,Substance,bone loss,Pathologic Function,PREVENTS
16177843,title,1,schizophrenia,Mental or Behavioral Dysfunction,cohort,Human,OCCURS_IN
16177843,abstract,7,schizophrenia,Mental or Behavioral Dysfunction,psychotic disorders,Mental or Behavioral Dysfunction,ISA
16177843,abstract,7,psychotic disorders,Mental or Behavioral Dysfunction,cohort,Human,OCCURS_IN
16181881,abstract,1,lone atrial fibrillation,Disease or Syndrome,patients,Human,PROCESS_OF
16181881,abstract,1,surgery,Therapeutic or Preventive Procedure,patients,Human,TREATS
16181881,abstract,1,surgery,Therapeutic or Preventive Procedure,lone atrial fibrillation,Disease or Syndrome,TREATS
16182253,abstract,1,cytoplasmic protein,"Amino Acid, Peptide, or Protein",metazoans,Invertebrate,PART_OF
16182253,abstract,1,nuclear,"Amino Acid, Peptide, or Protein",metazoans,Invertebrate,PART_OF
16182253,abstract,1,acetylglucosamine,Biologically Active Substance,cytoplasmic proteins,"Amino Acid, Peptide, or Protein",INTERACTS_WITH
16182253,abstract,1,acetylglucosamine,Biologically Active Substance,nuclear and cytoplasmic proteins,"Amino Acid, Peptide, or Protein",INTERACTS_WITH
16182253,abstract,6,Mutations,Genetic Function,progressive cerebellar ataxias,Disease or Syndrome,CAUSES
16182253,abstract,6,Mutations,Genetic Function,seizures,Sign or Symptom,CAUSES
16182253,abstract,6,SCA10 gene,Gene or Genome,Mutations,Genetic Function,LOCATION_OF
16182253,abstract,6,SCA10 gene,Gene or Genome,progressive cerebellar ataxias,Disease or Syndrome,CAUSES
16182253,abstract,6,SCA10 gene,Gene or Genome,seizures,Sign or Symptom,CAUSES
16182253,abstract,7,cells,Cell,O-linked glycosylation,Molecular Function,LOCATION_OF
16182253,abstract,7,O-linked glycosylation,Molecular Function,SCA10,Gene or Genome,AFFECTS
16182253,abstract,7,pancreatic beta cells,Cell,Ataxin-10 protein,"Amino Acid, Peptide, or Protein",LOCATION_OF
16182253,abstract,7,SCA10,Gene or Genome,OGT,"Amino Acid, Peptide, or Protein",INTERACTS_WITH
16185180,abstract,8,combination therapy,Therapeutic or Preventive Procedure,Patients,Human,TREATS
16185180,abstract,8,MDRPA,Disease or Syndrome,Patients,Human,PROCESS_OF
16185180,abstract,8,combination therapy,Therapeutic or Preventive Procedure,MDRPA,Disease or Syndrome,TREATS
16185180,abstract,8,combination therapy,Therapeutic or Preventive Procedure,beta-lactam,Antibiotic,USES
16185180,abstract,8,combination therapy,Therapeutic or Preventive Procedure,aminoglycoside,Pharmacologic Substance,USES
16185180,abstract,8,combination therapy,Therapeutic or Preventive Procedure,fluoroquinolone,Pharmacologic Substance,USES
16185321,abstract,1,Killer cell immunoglobulin-like receptors,"Amino Acid, Peptide, or Protein",human leukocyte antigen,"Amino Acid, Peptide, or Protein",INTERACTS_WITH
16194167,title,1,transthoracic echocardiography,Diagnostic Procedure,abdominal aortic atherosclerosis,Disease or Syndrome,DIAGNOSES
16194167,abstract,10,TTE,Diagnostic Procedure,patients,Human,ADMINISTERED_TO
16194167,abstract,10,TTE,Diagnostic Procedure,patients,Human,ADMINISTERED_TO
16194167,abstract,10,TTE,Diagnostic Procedure,images,Diagnostic Procedure,ISA
16197815,abstract,4,ALS,Disease or Syndrome,patients,Human,PROCESS_OF
16197815,abstract,4,IGF-1,"Amino Acid, Peptide, or Protein",patients,Human,ADMINISTERED_TO
16197815,abstract,6,ALS,Disease or Syndrome,patients,Human,PROCESS_OF
16197815,abstract,6,treatment,Therapeutic or Preventive Procedure,motor functions,Functional Concept,AFFECTS
16204062,abstract,3,PKCiota,"Amino Acid, Peptide, or Protein",isozyme,"Amino Acid, Peptide, or Protein",ISA
16204062,abstract,3,PKCiota,"Amino Acid, Peptide, or Protein",tumorigenicity,Pathologic Function,AFFECTS
16204062,abstract,3,PKCiota,"Amino Acid, Peptide, or Protein",human lung adenocarcinoma A549 cell line,Cell,AFFECTS
16204062,abstract,3,human lung adenocarcinoma A549 cell line,Cell,lung adenocarcinoma,Neoplastic Process,LOCATION_OF
16204062,abstract,3,cells,Cell,non-small cell lung cancer (NSCLC),Neoplastic Process,LOCATION_OF
16204062,abstract,3,cells,Cell,human,Human,PART_OF
16204062,abstract,3,non-small cell lung cancer (NSCLC),Neoplastic Process,human,Human,PROCESS_OF
16204062,abstract,3,atypical PKC (aPKC),"Amino Acid, Peptide, or Protein",isozyme,"Amino Acid, Peptide, or Protein",ISA
16204062,abstract,4,PKCiota,"Amino Acid, Peptide, or Protein",oncogene,Gene or Genome,ISA
16204062,abstract,4,oncogene,Gene or Genome,NSCLC,Neoplastic Process,ASSOCIATED_WITH
16204062,abstract,4,PKCiota,"Amino Acid, Peptide, or Protein",NSCLC,Neoplastic Process,ASSOCIATED_WITH
16204062,abstract,4,tumors,Neoplastic Process,aPKCiota,"Amino Acid, Peptide, or Protein",PRODUCES
16204062,abstract,4,NSCLC,Neoplastic Process,aPKCiota,"Amino Acid, Peptide, or Protein",PRODUCES
16204062,abstract,4,NSCLC,Neoplastic Process,tumors,Neoplastic Process,ISA
16204062,abstract,4,tumor,Neoplastic Process,PKCiota,"Amino Acid, Peptide, or Protein",PRODUCES
16204062,abstract,4,NSCLC,Neoplastic Process,patients,Human,PROCESS_OF
16204062,abstract,4,PKCiota,"Amino Acid, Peptide, or Protein",cell line,Cell,PART_OF
16204062,abstract,4,NSCLC,Neoplastic Process,cell lines,Cell,PART_OF
16204062,abstract,4,NSCLC,Neoplastic Process,tumors,Neoplastic Process,ISA
16204062,abstract,4,cell lines,Cell,NSCLC,Neoplastic Process,LOCATION_OF
16204062,abstract,4,PKCiota,"Amino Acid, Peptide, or Protein",tumor,Neoplastic Process,PART_OF
16204062,abstract,4,PKCiota,"Amino Acid, Peptide, or Protein",NSCLC,Neoplastic Process,PART_OF
16204062,abstract,4,PKCiota,"Amino Acid, Peptide, or Protein",cell line,Cell,PART_OF
16204062,abstract,4,PKCiota,"Amino Acid, Peptide, or Protein",tumor,Neoplastic Process,PART_OF
16204062,abstract,4,NSCLC,Neoplastic Process,tumors,Neoplastic Process,ISA
16204062,abstract,4,PKCiota,"Amino Acid, Peptide, or Protein",NSCLC,Neoplastic Process,PART_OF
16204062,abstract,4,gene amplification,Genetic Function,PKCiota,"Amino Acid, Peptide, or Protein",STIMULATES
16204062,abstract,4,allele,Gene or Genome,PKCiota,"Amino Acid, Peptide, or Protein",INHIBITS
16204062,abstract,4,cells,Cell,NSCLC,Neoplastic Process,LOCATION_OF
16204062,abstract,4,cells,Cell,gene amplification,Genetic Function,LOCATION_OF
16205318,title,1,Ipsapirone,Pharmacologic Substance,circulatory shock,Pathologic Function,PREVENTS
16205318,title,1,ketanserin,Pharmacologic Substance,circulatory shock,Pathologic Function,PREVENTS
16205318,title,1,Ipsapirone,Pharmacologic Substance,intracranial hypertension,Disease or Syndrome,PREVENTS
16205318,title,1,ketanserin,Pharmacologic Substance,intracranial hypertension,Disease or Syndrome,PREVENTS
16205318,title,1,Ipsapirone,Pharmacologic Substance,cerebral ischemia,Disease or Syndrome,PREVENTS
16205318,title,1,ketanserin,Pharmacologic Substance,cerebral ischemia,Disease or Syndrome,PREVENTS
16207633,abstract,5,cells,Cell,CHO,"Body Part, Organ, or Organ Component",PART_OF
16207633,abstract,5,cells,Cell,bone marrow,"Body Part, Organ, or Organ Component",PART_OF
16207633,abstract,6,cells,Cell,MDR1,Gene or Genome,LOCATION_OF
16207633,abstract,6,cells,Cell,MRP2,Gene or Genome,LOCATION_OF
16207633,abstract,6,MRP2 gene,Gene or Genome,Hepa c cells,Cell,PART_OF
16207633,abstract,6,MDR1,Gene or Genome,Hepa c cells,Cell,PART_OF
16216070,abstract,1,Cytochrome b5 reductase,"Amino Acid, Peptide, or Protein",cytochrome b5,"Amino Acid, Peptide, or Protein",INTERACTS_WITH
16216070,abstract,1,NADH,Biologically Active Substance,cytochrome b5,"Amino Acid, Peptide, or Protein",INHIBITS
16228202,abstract,2,yeast,Fungus,glucosylceramide,Biologically Active Substance,LOCATION_OF
16228202,abstract,2,glucosylceramide,Biologically Active Substance,yeast,Fungus,AFFECTS
16228202,abstract,3,yeast,Fungus,glucosylceramide,Biologically Active Substance,LOCATION_OF
16230392,abstract,2,EP2,Gene or Genome,tumorigenesis,Neoplastic Process,ASSOCIATED_WITH
16230392,abstract,2,mammary gland,"Body Part, Organ, or Organ Component",tumorigenesis,Neoplastic Process,LOCATION_OF
16230392,abstract,2,colon,"Body Part, Organ, or Organ Component",tumorigenesis,Neoplastic Process,LOCATION_OF
16230392,abstract,2,mammary gland,"Body Part, Organ, or Organ Component",mouse,Mammal,PART_OF
16230392,abstract,2,colon,"Body Part, Organ, or Organ Component",mouse,Mammal,PART_OF
16232237,abstract,13,cancer,Neoplastic Process,patients,Human,PROCESS_OF
16243512,abstract,4,beta-amyloid,"Amino Acid, Peptide, or Protein",Alzheimer's disease,Disease or Syndrome,CAUSES
16246439,abstract,6,placebo,Medical Device,candesartan,Pharmacologic Substance,COMPARED_WITH
16246439,abstract,6,candesartan,Pharmacologic Substance,CD40 ligand,"Amino Acid, Peptide, or Protein",INHIBITS
16246439,abstract,11,Candesartan,Pharmacologic Substance,inflammation,Pathologic Function,TREATS
16246439,abstract,11,Candesartan,Pharmacologic Substance,adiponectin,"Amino Acid, Peptide, or Protein",STIMULATES
16246439,abstract,11,Candesartan,Pharmacologic Substance,insulin sensitivity,Pathologic Function,TREATS
16246439,abstract,11,hypertensive,Finding,patients,Human,PROCESS_OF
16246439,abstract,11,insulin sensitivity,Pathologic Function,patients,Human,PROCESS_OF
16246439,abstract,11,inflammation,Pathologic Function,patients,Human,PROCESS_OF
16251535,abstract,7,microRNAs,"Nucleic Acid, Nucleoside, or Nucleotide",somatic mutations,Cell or Molecular Dysfunction,LOCATION_OF
16251535,abstract,7,microRNAs,"Nucleic Acid, Nucleoside, or Nucleotide",Germ-line,Genetic Function,LOCATION_OF
16251535,abstract,7,CLL,Neoplastic Process,patients,Human,PROCESS_OF
16251535,abstract,7,somatic mutation,Cell or Molecular Dysfunction,patients,Human,PROCESS_OF
16251535,abstract,7,Germ-line,Genetic Function,patients,Human,PROCESS_OF
16251535,abstract,7,mutations,Genetic Function,subjects,Human,PROCESS_OF
16251535,abstract,7,cancer,Neoplastic Process,subjects,Human,PROCESS_OF
16256984,abstract,1,Adherens junctions,Cell Component,vascular morphogenesis,Organ or Tissue Function,AFFECTS
16256984,abstract,1,cadherins,"Amino Acid, Peptide, or Protein",vascular morphogenesis,Organ or Tissue Function,AFFECTS
16256984,abstract,1,Adherens junctions,Cell Component,endothelial cell,Cell,AFFECTS
16256984,abstract,1,cadherins,"Amino Acid, Peptide, or Protein",endothelial cell,Cell,AFFECTS
16256984,abstract,1,cadherins,"Amino Acid, Peptide, or Protein",endothelial cell integrity and growth,Cell Function,AFFECTS
16256984,abstract,1,Adherens junctions,Cell Component,endothelial cell integrity and growth,Cell Function,AFFECTS
16256984,abstract,7,endothelium,Tissue,N-cadherin,"Amino Acid, Peptide, or Protein",LOCATION_OF
16256984,abstract,7,N-cadherin,"Amino Acid, Peptide, or Protein",VE-cadherin,"Amino Acid, Peptide, or Protein",INTERACTS_WITH
16260902,abstract,3,hepatitis A antigen,Immunologic Factor,Subjects,Human,ADMINISTERED_TO
16260962,abstract,3,CFS,Disease or Syndrome,patients,Human,PROCESS_OF
16260962,abstract,3,exercise stress test,Diagnostic Procedure,patients,Human,ADMINISTERED_TO
16260962,abstract,3,exercise stress test,Diagnostic Procedure,bicycle ergometer,Medical Device,USES
16260962,abstract,6,CFS,Disease or Syndrome,patients,Human,PROCESS_OF
16260962,abstract,6,performance,Individual Behavior,patients,Human,PROCESS_OF
16261927,abstract,2,opioid,Hazardous or Poisonous Substance,sedation,Sign or Symptom,CAUSES
16261927,abstract,2,sedation,Sign or Symptom,change in behaviour,Individual Behavior,AFFECTS
16266740,title,1,lead,Plant,rice grains,Hazardous or Poisonous Substance,LOCATION_OF
16266740,title,1,Cadmium,Plant,rice grains,Hazardous or Poisonous Substance,LOCATION_OF
16266740,title,1,rice,Plant,grains,Plant,ISA
16266740,abstract,1,Cadmium (Cd),Plant,rice,Hazardous or Poisonous Substance,LOCATION_OF
16266740,abstract,1,lead (Pb),Plant,rice,Hazardous or Poisonous Substance,LOCATION_OF
16266740,abstract,1,sampling site,Spatial Concept,survey,Research Activity,LOCATION_OF
16266740,abstract,1,rice,Plant,grains,Plant,ISA
16272203,abstract,8,contractility,Organ or Tissue Function,rats,Mammal,PROCESS_OF
16272824,abstract,7,supernatants,Body Substance,cells,Cell,PART_OF
16272824,abstract,7,supernatants,Body Substance,tumor necrosis factor-alpha,"Amino Acid, Peptide, or Protein",LOCATION_OF
16272824,abstract,7,supernatants,Body Substance,interleukin-8,"Amino Acid, Peptide, or Protein",LOCATION_OF
16272824,abstract,7,supernatants,Body Substance,IL-6,"Amino Acid, Peptide, or Protein",LOCATION_OF
16272824,abstract,12,human mast cell line,Cell,IL-6,"Amino Acid, Peptide, or Protein",LOCATION_OF
16272824,abstract,12,human mast cell line,Cell,TNF-alpha,"Amino Acid, Peptide, or Protein",LOCATION_OF
16272824,abstract,12,human mast cell line,Cell,IL-8,"Amino Acid, Peptide, or Protein",LOCATION_OF
16272824,abstract,14,SPS,Organic Chemical,allergic reaction,Pathologic Function,DISRUPTS
16272824,abstract,14,AD,Disease or Syndrome,disease,Disease or Syndrome,ISA
16272824,abstract,14,SPS,Organic Chemical,disease,Disease or Syndrome,TREATS
16272824,abstract,14,SPS,Organic Chemical,AD,Disease or Syndrome,TREATS
16280382,abstract,1,liver,"Body Part, Organ, or Organ Component",Wistar rats,Mammal,PART_OF
16280382,abstract,1,lung,"Body Part, Organ, or Organ Component",Wistar rats,Mammal,PART_OF
16280382,abstract,1,kidney,"Body Part, Organ, or Organ Component",Wistar rats,Mammal,PART_OF
16280382,abstract,9,AEST,Substance,inflammation,Pathologic Function,CAUSES
16280382,abstract,9,liver,"Body Part, Organ, or Organ Component",inflammation,Pathologic Function,LOCATION_OF
16280382,abstract,9,lung,"Body Part, Organ, or Organ Component",inflammation,Pathologic Function,LOCATION_OF
16284436,abstract,4,iodine deficiency,Disease or Syndrome,goiter,Disease or Syndrome,CAUSES
16284436,abstract,12,mutations,Genetic Function,signal transduction pathway,Cell Function,COEXISTS_WITH
16284436,abstract,12,SSCP,Laboratory or Test Result,screening,Health Care Activity,METHOD_OF
16284436,abstract,12,exon,"Nucleic Acid, Nucleoside, or Nucleotide",TSHR,"Amino Acid, Peptide, or Protein",PART_OF
16284524,abstract,9,TDR,Biologic Function,individuals,Human,PROCESS_OF
16284524,abstract,11,TDR,Biologic Function,individuals,Human,PROCESS_OF
16285448,abstract,3,study,Research Activity,phantom,Medical Device,USES
16285448,abstract,3,study,Research Activity,stent,Medical Device,USES
16288225,abstract,7,genes,Gene or Genome,T-cell activation,Cell Function,AFFECTS
16288225,abstract,7,genes,Gene or Genome,apoptosis,Cell Function,AFFECTS
16288225,abstract,7,NFKB1,Gene or Genome,genes,Gene or Genome,ISA
16288225,abstract,7,BCL-2,Gene or Genome,genes,Gene or Genome,ISA
16288225,abstract,7,NFKB1,Gene or Genome,T-cell activation,Cell Function,AFFECTS
16288225,abstract,7,BCL-2,Gene or Genome,T-cell activation,Cell Function,AFFECTS
16288225,abstract,7,NFKB1,Gene or Genome,apoptosis,Cell Function,AFFECTS
16288225,abstract,7,BCL-2,Gene or Genome,apoptosis,Cell Function,AFFECTS
16290001,abstract,2,cervical adenocarcinoma,Neoplastic Process,patients,Human,PROCESS_OF
16290001,abstract,2,radical hysterectomy,Therapeutic or Preventive Procedure,cervical adenocarcinoma,Neoplastic Process,TREATS
16290001,abstract,2,pelvic lymphadenectomy,Therapeutic or Preventive Procedure,cervical adenocarcinoma,Neoplastic Process,TREATS
16290001,abstract,3,pelvic,Body Location or Region,lymph node metastasis,Neoplastic Process,LOCATION_OF
16290001,abstract,3,lymph node metastasis,Neoplastic Process,patients,Human,PROCESS_OF
16291723,abstract,9,Rho-GEF,"Amino Acid, Peptide, or Protein",fission yeast,Fungus,PART_OF
16291815,abstract,1,Leydig cells,Cell,mice,Mammal,PART_OF
16291815,abstract,1,Leydig cells,Cell,ATP,Biologically Active Substance,LOCATION_OF
16296031,abstract,17,serum proteins,"Amino Acid, Peptide, or Protein",bovine,Mammal,PART_OF
16303761,abstract,2,c-met,"Amino Acid, Peptide, or Protein",HGF,Gene or Genome,INTERACTS_WITH
16303761,abstract,2,cells,Cell,receptor tyrosine kinase,"Amino Acid, Peptide, or Protein",PRODUCES
16303761,abstract,2,c-met,"Amino Acid, Peptide, or Protein",receptor tyrosine kinase,"Amino Acid, Peptide, or Protein",ISA
16303761,abstract,2,cells,Cell,c-met,"Amino Acid, Peptide, or Protein",PRODUCES
16303761,abstract,6,chymases,"Amino Acid, Peptide, or Protein",peptidases,"Amino Acid, Peptide, or Protein",ISA
16303761,abstract,6,mast cell,Cell,chymases,"Amino Acid, Peptide, or Protein",PRODUCES
16303761,abstract,6,chymases,"Amino Acid, Peptide, or Protein",HGF,Gene or Genome,INTERACTS_WITH
16303761,abstract,6,chymases,"Amino Acid, Peptide, or Protein",scatter factor,"Amino Acid, Peptide, or Protein",INHIBITS
16303761,abstract,6,chymases,"Amino Acid, Peptide, or Protein",antagonist,Chemical Viewed Functionally,PRODUCES
16303761,abstract,6,NK4,Gene or Genome,scatter factor activity,Molecular Function,DISRUPTS
16303761,abstract,10,cathepsin G,"Amino Acid, Peptide, or Protein",neutrophil,Cell,PART_OF
16303761,abstract,10,cathepsin G,"Amino Acid, Peptide, or Protein",Mast cell,Cell,PART_OF
16303761,abstract,10,neutrophil elastase,Gene or Genome,HGF,"Amino Acid, Peptide, or Protein",PRODUCES
16303761,abstract,10,neutrophil elastase,"Amino Acid, Peptide, or Protein",HGF,"Amino Acid, Peptide, or Protein",PRODUCES
16303761,abstract,10,elastase,"Amino Acid, Peptide, or Protein",neutrophil,Cell,PART_OF
16304222,title,1,anticoagulation,Therapeutic or Preventive Procedure,patients,Patient or Disabled Group,TREATS
16304222,title,1,patients,Human,mechanical heart valves,Medical Device,USES
16310382,abstract,1,Cystitis,Disease or Syndrome,cattle,Mammal,PROCESS_OF
16310382,abstract,1,urethritis,Disease or Syndrome,cattle,Mammal,PROCESS_OF
16310382,abstract,1,pyelonephritis,Disease or Syndrome,cattle,Mammal,PROCESS_OF
16310382,abstract,1,urinary tract infection,Disease or Syndrome,Cystitis,Disease or Syndrome,CAUSES
16310382,abstract,1,urinary tract infection,Disease or Syndrome,urethritis,Disease or Syndrome,CAUSES
16310382,abstract,1,urinary tract infection,Disease or Syndrome,pyelonephritis,Disease or Syndrome,CAUSES
16310382,abstract,1,Corynebacterium renale,Bacterium,urinary tract infection,Disease or Syndrome,CAUSES
16310382,abstract,1,Corynebacterium pilosum,Bacterium,urinary tract infection,Disease or Syndrome,CAUSES
16310382,abstract,1,Escherichia coli,Bacterium,urinary tract infection,Disease or Syndrome,CAUSES
16310382,abstract,1,urinary tract infection,Disease or Syndrome,pyelonephritis,Disease or Syndrome,CAUSES
16310382,abstract,2,urinary tract infection,Disease or Syndrome,dairy cattle,Mammal,PROCESS_OF
16310382,abstract,2,findings,Sign or Symptom,dairy cattle,Mammal,PROCESS_OF
16311763,abstract,4,PGC-1alpha,Gene or Genome,biogenesis,Natural Phenomenon or Process,AFFECTS
16311763,abstract,4,Tfam,Gene or Genome,biogenesis,Natural Phenomenon or Process,AFFECTS
16311763,abstract,4,mitochondrial,Cell Component,biogenesis,Natural Phenomenon or Process,LOCATION_OF
16311763,abstract,4,COX-1,"Amino Acid, Peptide, or Protein",mitochondrial,Cell Component,AFFECTS
16311763,abstract,4,COX-4,Gene or Genome,mitochondrial,Cell Component,AFFECTS
16311763,abstract,4,IGF-I,"Amino Acid, Peptide, or Protein",mechanical stress,Natural Phenomenon or Process,AFFECTS
16316352,abstract,1,CAD,Disease or Syndrome,patients,Human,PROCESS_OF
16316352,abstract,1,glomerular filtration rate,Organ or Tissue Function,patients,Human,PROCESS_OF
16316352,abstract,1,coronary artery disease,Disease or Syndrome,chronic renal failure,Disease or Syndrome,COEXISTS_WITH
16316352,abstract,1,renal hemodynamic dysfunction,Pathologic Function,chronic renal failure,Disease or Syndrome,COEXISTS_WITH
16316352,abstract,1,renal hemodynamic dysfunction,Pathologic Function,coronary artery disease (CAD),Disease or Syndrome,COEXISTS_WITH
16316352,abstract,13,CAD,Disease or Syndrome,patients,Human,PROCESS_OF
16316352,abstract,13,GFR,Organ or Tissue Function,patients,Human,PROCESS_OF
16317035,abstract,1,thylakoid lumen,Cell Component,cyanobacteria,Bacterium,PART_OF
16317035,abstract,1,thylakoid lumen,Cell Component,algae,Alga,PART_OF
16317035,abstract,1,algae,Alga,eukaryotic,Organism,ISA
16317035,abstract,1,Cytochrome c6,"Amino Acid, Peptide, or Protein",thylakoid lumen,Cell Component,PART_OF
16328214,abstract,7,biopsy,Diagnostic Procedure,Findings,Finding,DIAGNOSES
16328359,title,1,odontoclasts,Cell,Chinook salmon,Fish,PART_OF
16328359,abstract,1,odontoclasts,Cell,teeth,"Body Part, Organ, or Organ Component",PART_OF
16328359,abstract,1,teeth,"Body Part, Organ, or Organ Component",teleost fish,Fish,PART_OF
16328359,abstract,1,Chinook salmon,Fish,teleost fish,Fish,ISA
16328359,abstract,1,study,Laboratory Procedure,light microscope,Medical Device,USES
16328359,abstract,1,light microscope,Medical Device,transmission electron microscopy,Laboratory Procedure,PRECEDES
16330236,title,1,agonist,Pharmacologic Substance,Ovarian hyperstimulation,Pathologic Function,CAUSES
16332537,abstract,2,neurons,Cell,visual cortical,"Body Part, Organ, or Organ Component",PART_OF
16332961,abstract,2,mitochondria,Cell Component,respiratory chain,Cell Component,LOCATION_OF
16332961,abstract,2,respiratory chain,Cell Component,ROS,Biologically Active Substance,LOCATION_OF
16332961,abstract,2,respiratory chain,Molecular Function,degenerative diseases,Disease or Syndrome,AFFECTS
16332961,abstract,2,respiratory chain,Molecular Function,aging,Organism Function,AFFECTS
16332961,abstract,2,mitochondria,Cell Component,respiratory chain,Molecular Function,LOCATION_OF
16332961,abstract,2,respiratory chain,Molecular Function,ROS,Biologically Active Substance,PRODUCES
16338777,abstract,1,pelvic inflammatory disease,Disease or Syndrome,patients,Human,PROCESS_OF
16338777,abstract,1,PID,Disease or Syndrome,women,Human,PROCESS_OF
16338878,abstract,3,corpus callosum,"Body Part, Organ, or Organ Component",hypoplasia,Pathologic Function,LOCATION_OF
16338878,abstract,3,short umbilical cord,Anatomical Abnormality,single umbilical artery,Congenital Abnormality,COEXISTS_WITH
16339800,abstract,7,missense mutation,Genetic Function,PP2C activity,Molecular Function,DISRUPTS
16339800,abstract,7,ahg3-1,"Amino Acid, Peptide, or Protein",missense mutation,Genetic Function,LOCATION_OF
16339800,abstract,7,PP2C,"Amino Acid, Peptide, or Protein",signaling,Cell Function,DISRUPTS
16339800,abstract,7,signaling,Cell Function,ABA,Biologically Active Substance,AFFECTS
16340726,abstract,2,SPECT,Diagnostic Procedure,patients,Human,ADMINISTERED_TO
16340726,abstract,2,SPECT,Diagnostic Procedure,patients,Human,ADMINISTERED_TO
16340726,abstract,2,emphysema,Pathologic Function,patients,Human,PROCESS_OF
16340726,abstract,2,COPD,Disease or Syndrome,patients,Human,PROCESS_OF
16352184,abstract,9,procedure,Health Care Activity,patients,Human,TREATS
16352184,abstract,9,surgery,Therapeutic or Preventive Procedure,patients,Human,TREATS
16352184,abstract,9,surgery,Therapeutic or Preventive Procedure,procedure,Health Care Activity,COEXISTS_WITH
16361909,abstract,9,pelvic,Body Location or Region,radiographs,Diagnostic Procedure,LOCATION_OF
16361909,abstract,9,radiographs,Diagnostic Procedure,application,Health Care Activity,PRECEDES
16361909,abstract,9,application,Health Care Activity,radiographs,Diagnostic Procedure,PRECEDES
16361909,abstract,9,stabilization,Therapeutic or Preventive Procedure,radiographs,Diagnostic Procedure,PRECEDES
16362132,abstract,11,post-menopausal,Organism Function,women,Human,PROCESS_OF
16362132,abstract,11,pre-menopausal,Physiologic Function,women,Human,PROCESS_OF
16362132,abstract,11,post-menopausal,Organism Function,women,Human,PROCESS_OF
16362541,abstract,7,tetraplegia,Disease or Syndrome,participants,Human,PROCESS_OF
16371595,abstract,3,eggs,Cell,calcium spiking,Cell Function,LOCATION_OF
16371595,abstract,3,eggs,Cell,mammalian,Mammal,PART_OF
16371595,abstract,11,phosphoinositide signaling,Lipid,ventralizing signal,Cell Function,AFFECTS
16371595,abstract,11,strong ventralizing signal,Cell Function,Xenopus,Amphibian,PROCESS_OF
16372122,abstract,9,penile,"Body Part, Organ, or Organ Component",deformities,Congenital Abnormality,LOCATION_OF
16372122,abstract,9,deformities,Congenital Abnormality,patients,Human,PROCESS_OF
16372122,abstract,9,deformities,Congenital Abnormality,group,Human,PROCESS_OF
16372122,abstract,9,diabetic,Disease or Syndrome,group,Human,PROCESS_OF
16372122,abstract,10,PD,Disease or Syndrome,patients,Human,PROCESS_OF
16372122,abstract,10,DM,Disease or Syndrome,patients,Human,PROCESS_OF
16372122,abstract,13,DM,Disease or Syndrome,PD,Disease or Syndrome,CAUSES
16372122,abstract,13,diabetic,Finding,men,Human,PROCESS_OF
16372122,abstract,13,DM,Disease or Syndrome,men,Human,PROCESS_OF
16372914,abstract,2,choriocarcinoma,Neoplastic Process,malignancies,Neoplastic Process,ISA
16372914,abstract,2,seminoma,Neoplastic Process,malignancies,Neoplastic Process,ISA
16372914,abstract,2,ovarian carcinoma,Neoplastic Process,malignancies,Neoplastic Process,ISA
16372914,abstract,2,placental isozyme,"Amino Acid, Peptide, or Protein",oncofetal antigen,"Amino Acid, Peptide, or Protein",ISA
16372914,abstract,2,oncofetal antigen,"Amino Acid, Peptide, or Protein",malignancies,Neoplastic Process,PART_OF
16372914,abstract,2,placental isozyme,"Amino Acid, Peptide, or Protein",malignancies,Neoplastic Process,PART_OF
16372914,abstract,2,oncofetal antigen,"Amino Acid, Peptide, or Protein",choriocarcinoma,Neoplastic Process,PART_OF
16372914,abstract,2,oncofetal antigen,"Amino Acid, Peptide, or Protein",seminoma,Neoplastic Process,PART_OF
16372914,abstract,2,oncofetal antigen,"Amino Acid, Peptide, or Protein",ovarian carcinoma,Neoplastic Process,PART_OF
16372914,abstract,2,placental isozyme,"Amino Acid, Peptide, or Protein",choriocarcinoma,Neoplastic Process,PART_OF
16372914,abstract,2,placental isozyme,"Amino Acid, Peptide, or Protein",seminoma,Neoplastic Process,PART_OF
16372914,abstract,2,placental isozyme,"Amino Acid, Peptide, or Protein",ovarian carcinoma,Neoplastic Process,PART_OF
16373645,abstract,3,mRNA expression,Biologically Active Substance,Ccm2,"Amino Acid, Peptide, or Protein",PART_OF
16373645,abstract,3,mRNA expression,Biologically Active Substance,Ccm1,"Amino Acid, Peptide, or Protein",PART_OF
16373645,abstract,3,brain,"Body Part, Organ, or Organ Component",Ccm2,"Amino Acid, Peptide, or Protein",LOCATION_OF
16373645,abstract,3,brain,"Body Part, Organ, or Organ Component",Ccm1,"Amino Acid, Peptide, or Protein",LOCATION_OF
16373645,abstract,3,brain,"Body Part, Organ, or Organ Component",mouse,Mammal,PART_OF
16373645,abstract,4,cell lines,Cell,transfection,Genetic Function,LOCATION_OF
16373645,abstract,5,cerebral,"Body Part, Organ, or Organ Component",CCM2,"Amino Acid, Peptide, or Protein",LOCATION_OF
16373645,abstract,5,cerebral,"Body Part, Organ, or Organ Component",CCM1,"Amino Acid, Peptide, or Protein",LOCATION_OF
16373645,abstract,5,CCM2,"Amino Acid, Peptide, or Protein",CCM1,Gene or Genome,COMPARED_WITH
16373645,abstract,5,tissues,Tissue,CCM2 ,"Amino Acid, Peptide, or Protein",LOCATION_OF
16373645,abstract,5,tissues,Tissue,CCM1,"Amino Acid, Peptide, or Protein",LOCATION_OF
16376188,abstract,5,MRI,Diagnostic Procedure,patient,Human,ADMINISTERED_TO
16376188,abstract,5,patient,Human,implants,Medical Device,USES
16376670,title,1,Anterior uveitis,Disease or Syndrome,Langerhans cell histiocytosis,Disease or Syndrome,COEXISTS_WITH
16376670,title,1,Anterior uveitis,Finding,Langerhans cell histiocytosis,Disease or Syndrome,COEXISTS_WITH
16376670,abstract,5,inflammation,Pathologic Function,patient,Human,PROCESS_OF
16376670,abstract,5,iris nodules,Finding,patient,Human,PROCESS_OF
16376670,abstract,5,topical corticosteroids,Pharmacologic Substance,patient,Human,TREATS
16376670,abstract,5,topical corticosteroids,Pharmacologic Substance,inflammation,Pathologic Function,TREATS
16376670,abstract,5,topical corticosteroids,Pharmacologic Substance,iris nodules,Finding,TREATS
16380233,abstract,8,phospholipid,Biologically Active Substance,fatty acid,Biologically Active Substance,ISA
16380233,abstract,8,fatty acid,Lipid,carbon,"Element, Ion, or Isotope",INTERACTS_WITH
16380233,abstract,8,phospholipid,Biologically Active Substance,fatty acid,"Element, Ion, or Isotope",INTERACTS_WITH
16387100,abstract,12,ESRD,Disease or Syndrome,glomerulopathy,Disease or Syndrome,MANIFESTATION_OF
16387100,abstract,12,glomerulopathy,Disease or Syndrome,IgAN,Disease or Syndrome,COEXISTS_WITH
16387100,abstract,12,glomerulopathy,Disease or Syndrome,FSG,Disease or Syndrome,COEXISTS_WITH
16387100,abstract,12,glomerulopathy,Disease or Syndrome,MCGN,Disease or Syndrome,COEXISTS_WITH
16387100,abstract,12,glomerulopathy,Disease or Syndrome,membranous GN,Disease or Syndrome,COEXISTS_WITH
16394795,abstract,10,Manometry,Laboratory Procedure,anal sphincter resting pressure,Finding,DIAGNOSES
16394795,abstract,10,food intolerance,Sign or Symptom,patients,Human,PROCESS_OF
16394795,abstract,10,constipation,Sign or Symptom,patients,Human,PROCESS_OF
16394795,abstract,10,constipation,Sign or Symptom,food intolerance,Sign or Symptom,COEXISTS_WITH
16394795,abstract,12,Food intolerance,Sign or Symptom,constipation,Sign or Symptom,AFFECTS
16394795,abstract,12,proctitis,Disease or Syndrome,constipation,Sign or Symptom,MANIFESTATION_OF
16395331,abstract,1,Cell cycle progression,Cell Function,Caulobacter,Bacterium,PROCESS_OF
16395331,abstract,1,CtrA,"Amino Acid, Peptide, or Protein",transcriptional regulators,"Amino Acid, Peptide, or Protein",ISA
16395331,abstract,1,transcriptional regulators,"Amino Acid, Peptide, or Protein",Cell cycle progression,Cell Function,AFFECTS
16395331,abstract,1,CtrA,"Amino Acid, Peptide, or Protein",Cell cycle progression,Cell Function,AFFECTS
16402182,abstract,5,lymphocytes,Cell,Splenic,"Body Part, Organ, or Organ Component",PART_OF
16402182,abstract,5,B-cells,Cell,BALB/c mice,Mammal,PART_OF
16407061,abstract,5,extracellular,Cell Component,virion,Cell Component,LOCATION_OF
16407061,abstract,5,virion,Cell Component,core,"Amino Acid, Peptide, or Protein",LOCATION_OF
16407061,abstract,5,viral membrane,Cell Component,growth,Organism Function,DISRUPTS
16411510,abstract,3,leprosy,Disease or Syndrome,people,Human,AFFECTS
16411522,title,1,removal and reinsertion of peritoneal dialysis catheter,Therapeutic or Preventive Procedure,pseudomonas aeruginosa exit-site infection,Disease or Syndrome,TREATS
16411522,title,1,reinsertion of peritoneal dialysis catheter,Therapeutic or Preventive Procedure,pseudomonas aeruginosa exit-site infection,Disease or Syndrome,TREATS
16411522,abstract,8,CAPD,Therapeutic or Preventive Procedure,patients,Human,ADMINISTERED_TO
16411522,abstract,8,operation,Therapeutic or Preventive Procedure,patients,Patient or Disabled Group,ADMINISTERED_TO
16412044,title,1,active immunization,Therapeutic or Preventive Procedure,cardiomyopathic,Disease or Syndrome,CAUSES
16412044,title,1,synthetic peptide,"Amino Acid, Peptide, or Protein",rats,Mammal,ADMINISTERED_TO
16412044,title,1,synthetic peptide,"Amino Acid, Peptide, or Protein",beta-adrenergic receptor,"Amino Acid, Peptide, or Protein",PART_OF
16412044,title,1,beta-adrenergic receptor,"Amino Acid, Peptide, or Protein",human,Human,PART_OF
16412044,abstract,1,heart,"Body Part, Organ, or Organ Component",human,Human,PART_OF
16415554,abstract,2,steroid therapy,Therapeutic or Preventive Procedure,patient,Human,TREATS
16415554,abstract,3,Systemic lupus erythematosus,Disease or Syndrome,gastrointestinal symptoms,Sign or Symptom,COEXISTS_WITH
16415554,abstract,3,colonic,"Body Part, Organ, or Organ Component",lesions,Finding,LOCATION_OF
16418362,title,1,subthalamic nucleus,"Body Part, Organ, or Organ Component",human,Human,PART_OF
16418362,abstract,6,deep-brain stimulation,Therapeutic or Preventive Procedure,PD,Disease or Syndrome,TREATS
16418362,abstract,6,deep-brain stimulation,Therapeutic or Preventive Procedure,patients,Human,ADMINISTERED_TO
16418362,abstract,6,STN,"Body Part, Organ, or Organ Component",patients,Human,PART_OF
16418362,abstract,12,STN,"Body Part, Organ, or Organ Component",human,Human,PART_OF
16424791,abstract,8,atherosclerosis,Disease or Syndrome,mice,Mammal,PROCESS_OF
16424791,abstract,8,Treatment,Therapeutic or Preventive Procedure,atherosclerosis,Disease or Syndrome,PREVENTS
16424791,abstract,8,Treatment,Therapeutic or Preventive Procedure,amlodipine,Pharmacologic Substance,USES
16424791,abstract,8,amlodipine,Pharmacologic Substance,atherosclerosis,Disease or Syndrome,PREVENTS
16424791,abstract,8,CRP,Immunologic Factor,mice,Mammal,ADMINISTERED_TO
16424791,abstract,8,CRP,"Amino Acid, Peptide, or Protein",mice,Mammal,ADMINISTERED_TO
16425104,abstract,4,Lymnaea stagnalis,Invertebrate,snail,Invertebrate,ISA
16430036,abstract,8,prostate cancer,Neoplastic Process,patients,Human,PROCESS_OF
16430036,abstract,8,prostate cancer,Neoplastic Process,patients,Human,PROCESS_OF
16430036,abstract,17,mucosa,Tissue,injury,Injury or Poisoning,LOCATION_OF
16430036,abstract,17,prostatic urethra,"Body Part, Organ, or Organ Component",injury,Injury or Poisoning,LOCATION_OF
16430036,abstract,17,injury,Injury or Poisoning,patient,Human,PROCESS_OF
16430036,abstract,17,bladder catheter,Medical Device,injury,Injury or Poisoning,TREATS
16430036,abstract,17,injury,Injury or Poisoning,rectal fistula,Anatomical Abnormality,CAUSES
16430741,abstract,4,temporomandibular joint,"Body Part, Organ, or Organ Component",human,Human,PART_OF
16430741,abstract,4,synovial cells,Cell,temporomandibular joint,"Body Part, Organ, or Organ Component",PART_OF
16431130,abstract,5,prosimian,Mammal,primates,Mammal,ISA
16431130,abstract,5,Lemur catta,Mammal,primates,Mammal,ISA
16436670,abstract,4,IFN-alpha,"Amino Acid, Peptide, or Protein",cytoskeletal organization,Cell Function,AFFECTS
16436670,abstract,4,hairy cells,Cell,cytoskeletal organization,Cell Function,LOCATION_OF
16436670,abstract,5,IFN-alpha,"Amino Acid, Peptide, or Protein",GTPase,"Amino Acid, Peptide, or Protein",INTERACTS_WITH
16436670,abstract,5,hairy cells,Cell,GTPase,"Amino Acid, Peptide, or Protein",LOCATION_OF
16436670,abstract,7,hairy cells,Cell,RhoA,Gene or Genome,LOCATION_OF
16436670,abstract,7,IFN-alpha,"Amino Acid, Peptide, or Protein",RhoA,Gene or Genome,STIMULATES
16440178,abstract,1,epithelium,Tissue,uterine,"Body Part, Organ, or Organ Component",PART_OF
16440178,abstract,1,uterine,"Body Part, Organ, or Organ Component",fluid,Body Substance,LOCATION_OF
16441715,title,1,sino-atrial disease,Disease or Syndrome,patients,Human,PROCESS_OF
16441715,title,1,pacemaker,Medical Device,patients,Patient or Disabled Group,TREATS
16441715,title,1,pacemaker,Medical Device,sino-atrial disease,Disease or Syndrome,TREATS
16445747,title,1,Ustilago maydis,Fungus,Promoters,Biologically Active Substance,LOCATION_OF
16445747,title,1,fungi,Fungus,Promoters,Biologically Active Substance,LOCATION_OF
16445747,abstract,3,Prf1,"Amino Acid, Peptide, or Protein",response element,Biologically Active Substance,INTERACTS_WITH
16445747,abstract,3,Prf1,"Amino Acid, Peptide, or Protein",high mobility group box protein,"Amino Acid, Peptide, or Protein",ISA
16445747,abstract,3,Matalpha2,"Amino Acid, Peptide, or Protein",Mata1,"Amino Acid, Peptide, or Protein",INTERACTS_WITH
16445747,abstract,3,DNA binding,Genetic Function,yeast,Fungus,PROCESS_OF
16445747,abstract,3,Matalpha2,"Amino Acid, Peptide, or Protein",yeast,Fungus,PART_OF
16455026,title,1,endocrine therapy,Therapeutic or Preventive Procedure,breast cancer,Neoplastic Process,TREATS
16455026,abstract,2,breast cancer tissue,Tissue,estrogen receptor,"Amino Acid, Peptide, or Protein",LOCATION_OF
16455026,abstract,2,tissue,Tissue,breast cancer,Neoplastic Process,PART_OF
16455026,abstract,3,Tamoxifen,Pharmacologic Substance,hormonal receptors,"Amino Acid, Peptide, or Protein",INHIBITS
16455026,abstract,3,breast cancer cells,Cell,hormonal receptors,"Amino Acid, Peptide, or Protein",LOCATION_OF
16455026,abstract,3,breast cancer,Neoplastic Process,woman,Human,PROCESS_OF
16455026,abstract,3,adjuvant therapy,Therapeutic or Preventive Procedure,Tamoxifen,Pharmacologic Substance,USES
16455026,abstract,3,adjuvant therapy,Therapeutic or Preventive Procedure,woman,Human,TREATS
16455026,abstract,3,adjuvant therapy,Therapeutic or Preventive Procedure,breast cancer,Neoplastic Process,TREATS
16455026,abstract,3,Tamoxifen,Pharmacologic Substance,woman,Human,TREATS
16455026,abstract,3,Tamoxifen,Pharmacologic Substance,breast cancer,Neoplastic Process,TREATS
16460640,abstract,15,trauma,Injury or Poisoning,patients,Human,PROCESS_OF
16460640,abstract,15,non-trauma,Injury or Poisoning,patients,Human,PROCESS_OF
16460640,abstract,20,HIV-positive,Finding,surgical patients,Human,PROCESS_OF
16461476,abstract,1,enema,Therapeutic or Preventive Procedure,ulcerative colitis,Disease or Syndrome,TREATS
16461476,abstract,1,enema,Therapeutic or Preventive Procedure,Butyrate,Lipid,USES
16461476,abstract,1,Butyrate,Lipid,ulcerative colitis,Disease or Syndrome,TREATS
16462770,abstract,4,MKP1/CL100,Gene or Genome,JNK,"Amino Acid, Peptide, or Protein",INTERACTS_WITH
16462770,abstract,4,bronchial epithelia,"Body Part, Organ, or Organ Component",MKP1,Gene or Genome,LOCATION_OF
16462770,abstract,4,tissue samples,Tissue,NSCLC,Neoplastic Process,PART_OF
16462770,abstract,4,cytoplasm,Cell Component,MKP1,Gene or Genome,LOCATION_OF
16462770,abstract,4,nuclei,Cell Component,MKP1,Gene or Genome,LOCATION_OF
16462770,abstract,6,cisplatin,Inorganic Chemical,JNK,"Amino Acid, Peptide, or Protein",STIMULATES
16462770,abstract,6,cisplatin,Inorganic Chemical,p38,Gene or Genome,STIMULATES
16462770,abstract,6,cells,Cell,MKP1,Gene or Genome,LOCATION_OF
16462770,abstract,6,small-interfering RNA,Biologically Active Substance,MKP1,Gene or Genome,INTERACTS_WITH
16462770,abstract,11,cisplatin,Inorganic Chemical,cell death,Cell Function,CAUSES
16462770,abstract,11,cell death,Cell Function,NSCLC,Neoplastic Process,COEXISTS_WITH
16462770,abstract,11,MKP1,Gene or Genome,cell growth,Cell Function,AFFECTS
16462770,abstract,11,cell growth,Cell Function,mice,Mammal,PROCESS_OF
16470169,abstract,5,Rho,"Amino Acid, Peptide, or Protein",PI3K,"Amino Acid, Peptide, or Protein",STIMULATES
16470169,abstract,5,Rho,"Amino Acid, Peptide, or Protein",Akt,"Amino Acid, Peptide, or Protein",STIMULATES
16470169,abstract,5,Rho,"Amino Acid, Peptide, or Protein",PI3K,"Amino Acid, Peptide, or Protein",INHIBITS
16470169,abstract,5,Rho,"Amino Acid, Peptide, or Protein",Akt,"Amino Acid, Peptide, or Protein",INHIBITS
16470989,abstract,7,disability,Pathologic Function,depressive symptoms,Sign or Symptom,PREDISPOSES
16479855,abstract,9,Balloon dilatation,Therapeutic or Preventive Procedure,stricture,Anatomical Abnormality,TREATS
16479855,abstract,9,Balloon dilatation,Therapeutic or Preventive Procedure,stricture,Anatomical Abnormality,TREATS
16479855,abstract,9,Balloon dilatation,Therapeutic or Preventive Procedure,stricture,Anatomical Abnormality,TREATS
16480563,abstract,2,Down's syndrome,Disease or Syndrome,Participants,Human,PROCESS_OF
16480563,abstract,2,non-Down syndrome,Disease or Syndrome,participants,Human,PROCESS_OF
16480563,abstract,2,learning disabled,Mental or Behavioral Dysfunction,participants,Human,PROCESS_OF
16483645,title,1,vaginal,"Body Part, Organ, or Organ Component",estrogen receptor-alpha,"Amino Acid, Peptide, or Protein",LOCATION_OF
16483645,title,1,tissues,Tissue,estrogen receptor-alpha,"Amino Acid, Peptide, or Protein",LOCATION_OF
16483645,title,1,tissues,Tissue,tumor,Neoplastic Process,PART_OF
16483645,title,1,TVT,Neoplastic Process,bitches,Mammal,PROCESS_OF
16483645,title,1,tissues,Tissue,bitches,Mammal,PART_OF
16483645,abstract,1,neoplasms,Neoplastic Process,canine,Mammal,PROCESS_OF
16483645,abstract,1,transmissible venereal tumor,Neoplastic Process,neoplasms,Neoplastic Process,ISA
16483645,abstract,1,transmissible venereal tumor,Neoplastic Process,canine,Mammal,PROCESS_OF
16483645,abstract,1,transmissible venereal tumor,Neoplastic Process,female genital tract,"Body Part, Organ, or Organ Component",AFFECTS
16483645,abstract,8,endothelium,Tissue,blood vessels,"Body Part, Organ, or Organ Component",PART_OF
16483645,abstract,8,tissues,Tissue,ER-alpha,"Amino Acid, Peptide, or Protein",LOCATION_OF
16483645,abstract,8,neoplastic,Neoplastic Process,tissues,Tissue,LOCATION_OF
16496259,abstract,13,antiglaucomatous medications,Pharmacologic Substance,IOP,Disease or Syndrome,TREATS
16496259,abstract,13,medications,Pharmacologic Substance,antiglaucomatous,Disease or Syndrome,TREATS
16496259,abstract,13,eyes,"Body Part, Organ, or Organ Component",IOP,Disease or Syndrome,LOCATION_OF
16496495,abstract,9,Organophosphates,Organic Chemical,fatalities,Organism Function,AFFECTS
16496495,abstract,9,rat,Mammal,poison,Hazardous or Poisonous Substance,LOCATION_OF
16496495,abstract,10,Organophosphates,Organic Chemical,APP,Injury or Poisoning,CAUSES
16496495,abstract,10,poison,Hazardous or Poisonous Substance,APP,Injury or Poisoning,CAUSES
16496495,abstract,10,rat,Mammal,poison,Hazardous or Poisonous Substance,LOCATION_OF
16498946,abstract,3,promoter,Biologically Active Substance,gene,Gene or Genome,PART_OF
16498946,abstract,3,promoter,Biologically Active Substance,genetic alterations,Genetic Function,LOCATION_OF
16503396,abstract,11,Combined treatment,Therapeutic or Preventive Procedure,patients,Human,TREATS
16503396,abstract,11,tongue cancer,Neoplastic Process,patients,Human,PROCESS_OF
16503396,abstract,11,Combined treatment,Therapeutic or Preventive Procedure,tongue cancer,Neoplastic Process,TREATS
16503761,abstract,1,Thiazolidinediones (TZDs),Organic Chemical,peroxisomal proliferator-activated receptor (PPAR)-gamma agonists,Pharmacologic Substance,ISA
16503761,abstract,1,Thiazolidinediones,Organic Chemical,peroxisomal proliferator-activated receptor (PPAR)-gamma,Gene or Genome,STIMULATES
16503761,abstract,7,TZDs,Pharmacologic Substance,disease,Disease or Syndrome,TREATS
16503761,abstract,7,non-alcoholic fatty liver,Disease or Syndrome,disease,Disease or Syndrome,ISA
16503761,abstract,7,TZDs,Pharmacologic Substance,non-alcoholic fatty liver,Disease or Syndrome,TREATS
16503761,abstract,7,TZDs,Pharmacologic Substance,hepatic fat accumulation,Finding,DISRUPTS
16503761,abstract,7,TZDs,Pharmacologic Substance,polycystic ovary syndrome,Disease or Syndrome,TREATS
16503761,abstract,7,TZDs,Pharmacologic Substance,ovulation,Organ or Tissue Function,AUGMENTS
16503761,abstract,7,TZDs,Pharmacologic Substance,hirsutism,Finding,TREATS
16503761,abstract,7,TZDs,Pharmacologic Substance,endothelial dysfunction,Disease or Syndrome,TREATS
16503761,abstract,7,TZDs,Pharmacologic Substance,lipodystrophies,Disease or Syndrome,TREATS
16503761,abstract,7,TZDs,Pharmacologic Substance,liver size,Finding,AFFECTS
16504132,abstract,10,Cu2+,Biologically Active Substance,cells,Cell,AUGMENTS
16504132,abstract,10,cells,Cell,cyanobacterial,Bacterium,PART_OF
16504132,abstract,10,lysogenic,Biologic Function,cyanobacterial,Bacterium,PROCESS_OF
16507901,abstract,6,tissue,Tissue,colorectal tumor,Neoplastic Process,PART_OF
16507901,abstract,6,cell line,Cell,colon cancer,Neoplastic Process,PART_OF
16507901,abstract,6,COL4A5,Gene or Genome,colon cancer,Neoplastic Process,ASSOCIATED_WITH
16507901,abstract,6,COL4A6,Gene or Genome,colon cancer,Neoplastic Process,ASSOCIATED_WITH
16507901,abstract,6,COL4A5,Gene or Genome,colorectal tumor,Neoplastic Process,ASSOCIATED_WITH
16507901,abstract,6,COL4A6,Gene or Genome,colorectal tumor,Neoplastic Process,ASSOCIATED_WITH
16507901,abstract,6,promoter region,Biologically Active Substance,COL4A6,Gene or Genome,PART_OF
16507901,abstract,6,promoter region,Biologically Active Substance,COL4A5,Gene or Genome,PART_OF
16510729,abstract,1,nucleus accumbens,"Body Part, Organ, or Organ Component",dopamine D3 receptor,"Amino Acid, Peptide, or Protein",LOCATION_OF
16510729,abstract,1,dopamine D3 receptor,"Amino Acid, Peptide, or Protein",reward,Mental Process,AFFECTS
16510729,abstract,1,dopamine D3 receptor,"Amino Acid, Peptide, or Protein",reinforcement,Mental Process,AFFECTS
16513142,abstract,2,disorders,Disease or Syndrome,human,Human,PROCESS_OF
16513142,abstract,2,sequences,Nucleotide Sequence,disorders,Disease or Syndrome,ASSOCIATED_WITH
16513142,abstract,2,sequences,"Nucleic Acid, Nucleoside, or Nucleotide",meiotic recombination,Cell Function,AFFECTS
16513142,abstract,2,sequences,"Nucleic Acid, Nucleoside, or Nucleotide",chromosomal breaks,Cell or Molecular Dysfunction,AFFECTS
16513142,abstract,2,sequences,"Nucleic Acid, Nucleoside, or Nucleotide",transcriptional regulation,Cell Function,AFFECTS
16513142,abstract,3,DNA secondary structures,"Nucleic Acid, Nucleoside, or Nucleotide",DNA synthesis,Genetic Function,AFFECTS
16513142,abstract,3,repetitive sequences,Nucleotide Sequence,minisatellites,"Nucleic Acid, Nucleoside, or Nucleotide",PART_OF
16513142,abstract,3,repetitive sequences,Nucleotide Sequence,triplet repeats,"Nucleic Acid, Nucleoside, or Nucleotide",PART_OF
16513142,abstract,3,repetitive sequences,Nucleotide Sequence,telomeres,Cell Component,PART_OF
16519885,abstract,4,Rho target,"Amino Acid, Peptide, or Protein",myosin II,"Amino Acid, Peptide, or Protein",INTERACTS_WITH
16519885,abstract,4,Rho target,"Amino Acid, Peptide, or Protein",myosin II ATPase,"Amino Acid, Peptide, or Protein",INTERACTS_WITH
16531862,title,1,acetabulum,"Body Part, Organ, or Organ Component",fractures,Injury or Poisoning,LOCATION_OF
16531862,title,1,spine,"Body Part, Organ, or Organ Component",fractures,Injury or Poisoning,LOCATION_OF
16531862,abstract,7,spine fracture,Injury or Poisoning,patients,Human,PROCESS_OF
16531862,abstract,9,acetabulum,"Body Part, Organ, or Organ Component",fractures,Injury or Poisoning,LOCATION_OF
16531862,abstract,9,fractures,Injury or Poisoning,patients,Human,PROCESS_OF
16531862,abstract,9,thoracolumbar,Spatial Concept,injury,Injury or Poisoning,LOCATION_OF
16531862,abstract,9,injury,Injury or Poisoning,patients,Human,PROCESS_OF
16531862,abstract,9,spine injury,Injury or Poisoning,patients,Human,PROCESS_OF
16531862,abstract,9,spine injury,Injury or Poisoning,injury,Injury or Poisoning,ISA
16531984,abstract,1,interleukin 1-beta,"Amino Acid, Peptide, or Protein",cytokines,"Amino Acid, Peptide, or Protein",ISA
16531984,abstract,1,tumor necrosis factor-alpha,"Amino Acid, Peptide, or Protein",cytokines,"Amino Acid, Peptide, or Protein",ISA
16531984,abstract,1,5-lipoxygenase,"Amino Acid, Peptide, or Protein",enzyme,Enzyme,ISA
16531984,abstract,1,5-lipoxygenase,"Amino Acid, Peptide, or Protein",arachidonic acid,Eicosanoid,STIMULATES
16531984,abstract,11,ESRD,Disease or Syndrome,patients,Human,PROCESS_OF
16531984,abstract,11,PBMCs,Cell,ESRD,Human,PART_OF
16531984,abstract,11,Omega-3,Pharmacologic Substance,oxidative stress,Cell or Molecular Dysfunction,PREVENTS
16540467,abstract,4,APL,Neoplastic Process,patients,Human,PROCESS_OF
16540467,abstract,6,PML,Gene or Genome,PML-RARalpha,"Amino Acid, Peptide, or Protein",INTERACTS_WITH
16540467,abstract,6,PML,Gene or Genome,transcription,Genetic Function,AUGMENTS
16540467,abstract,6,RA,Organic Chemical,transcription,Genetic Function,AFFECTS
16540467,abstract,6,PML-RARalpha,"Amino Acid, Peptide, or Protein",transcription,Genetic Function,DISRUPTS
16543714,title,1,regimens,Therapeutic or Preventive Procedure,paricalcitol,Pharmacologic Substance,USES
16543714,title,1,regimens,Therapeutic or Preventive Procedure,secondary hyperparathyroidism,Disease or Syndrome,TREATS
16543714,title,1,paricalcitol,Pharmacologic Substance,secondary hyperparathyroidism,Disease or Syndrome,TREATS
16543714,title,1,secondary hyperparathyroidism,Disease or Syndrome,CKD,Disease or Syndrome,COEXISTS_WITH
16543714,abstract,1,calcitriol,Pharmacologic Substance,secondary hyperparathyroidism,Disease or Syndrome,TREATS
16543714,abstract,1,calcitriol,Pharmacologic Substance,parathyroid hormone,Hormone,INHIBITS
16543714,abstract,9,CKD,Disease or Syndrome,patients,Human,PROCESS_OF
16543714,abstract,9,SHPT,Disease or Syndrome,patients,Human,PROCESS_OF
16543714,abstract,9,paricalcitol,Pharmacologic Substance,patients,Human,TREATS
16543714,abstract,9,paricalcitol,Pharmacologic Substance,CKD,Pathologic Function,TREATS
16543714,abstract,9,paricalcitol,Pharmacologic Substance,SHPT,Disease or Syndrome,TREATS
16543714,abstract,10,regimen,Research Activity,placebo,Medical Device,COMPARED_WITH
16543714,abstract,10,regimen,Research Activity,hyperphosphatemia,Disease or Syndrome,AFFECTS
16543714,abstract,10,regimen,Research Activity,hypercalcemia,Disease or Syndrome,AFFECTS
16549534,abstract,8,mutations,Genetic Function,patients,Human,PROCESS_OF
16549534,abstract,8,DJS,Disease or Syndrome,patients,Human,PROCESS_OF
16549534,abstract,8,mutations,Genetic Function,MRP2,Gene or Genome,LOCATION_OF
16549534,abstract,8,ATP-binding cassettes (ABC),Biologically Active Substance,MRP2,Biologically Active Substance,PART_OF
16549534,abstract,9,DJS,Disease or Syndrome,neonatal,Human,PROCESS_OF
16549534,abstract,9,follow-up,Health Care Activity,DJS,Disease or Syndrome,TREATS
16549534,abstract,9,MRP2,Gene or Genome,disease,Disease or Syndrome,ASSOCIATED_WITH
16551631,abstract,5,CDC2,Gene or Genome,cells,Cell,PART_OF
16554223,title,1,pulmonary angiography,Diagnostic Procedure,imaging test,Diagnostic Procedure,ISA
16554223,title,1,imaging,Diagnostic Procedure,acute pulmonary embolism,Pathologic Function,DIAGNOSES
16554223,abstract,1,imaging,Diagnostic Procedure,acute pulmonary embolism,Disease or Syndrome,DIAGNOSES
16555656,abstract,2,incisors,"Body Part, Organ, or Organ Component",bovine,Mammal,PART_OF
16556753,abstract,1,anterior cruciate ligament,"Body Part, Organ, or Organ Component",reconstruction,Therapeutic or Preventive Procedure,LOCATION_OF
16569841,title,1,beta-lactamase,"Amino Acid, Peptide, or Protein",Kluyvera ascorbata,Bacterium,PART_OF
16584203,title,1,Hansenula polymorpha,Fungus,copper amine oxidase,"Amino Acid, Peptide, or Protein",LOCATION_OF
16594738,abstract,8,performance,Individual Behavior,participant,Human,PROCESS_OF
16594738,abstract,9,performance,Individual Behavior,participant,Human,PROCESS_OF
16594738,abstract,13,performance,Individual Behavior,Participant,Human,PROCESS_OF
16597919,title,1,Calcitonin gene-related peptide,"Amino Acid, Peptide, or Protein",monocyte chemoattractant protein-1,"Amino Acid, Peptide, or Protein",INHIBITS
16597919,title,1,type II alveolar epithelial cells,Cell,monocyte chemoattractant protein-1,"Amino Acid, Peptide, or Protein",LOCATION_OF
16597919,title,1,interleukin-1beta,"Amino Acid, Peptide, or Protein",monocyte chemoattractant protein-1,"Amino Acid, Peptide, or Protein",STIMULATES
16597919,abstract,8,CGRP,"Amino Acid, Peptide, or Protein",reactive oxygen species,Biologically Active Substance,INHIBITS
16597919,abstract,8,IL-1beta,"Amino Acid, Peptide, or Protein",reactive oxygen species,Biologically Active Substance,STIMULATES
16597919,abstract,9,IL-1beta,"Amino Acid, Peptide, or Protein",ROS,Biologically Active Substance,STIMULATES
16597919,abstract,9,intracellular,Cell Component,cAMP,"Nucleic Acid, Nucleoside, or Nucleotide",LOCATION_OF
16597919,abstract,9,cAMP,"Nucleic Acid, Nucleoside, or Nucleotide",CGRP,"Amino Acid, Peptide, or Protein",INTERACTS_WITH
16597919,abstract,9,CGRP,"Amino Acid, Peptide, or Protein",MCP-1,"Amino Acid, Peptide, or Protein",INHIBITS
16597919,abstract,9,CGRP,"Amino Acid, Peptide, or Protein",NF-kappaB,"Amino Acid, Peptide, or Protein",INHIBITS
16597919,abstract,9,CGRP,"Amino Acid, Peptide, or Protein",ROS ,Biologically Active Substance,INHIBITS
16606611,abstract,5,EKLF,"Amino Acid, Peptide, or Protein",promoters,Biologically Active Substance,INTERACTS_WITH
16606611,abstract,5,promoters,Biologically Active Substance,globin,"Amino Acid, Peptide, or Protein",PART_OF
16606611,abstract,5,globin,"Amino Acid, Peptide, or Protein",adult,Human,PART_OF
16608828,abstract,1,radon,"Element, Ion, or Isotope",lung cancer,Neoplastic Process,PREDISPOSES
16608828,abstract,1,radon,"Element, Ion, or Isotope",deaths,Finding,CAUSES
16608828,abstract,1,lung cancer,Neoplastic Process,deaths,Finding,CAUSES
16608828,abstract,4,lung,"Body Part, Organ, or Organ Component",carcinogen,Hazardous or Poisonous Substance,LOCATION_OF
16617173,abstract,5,meditation,Therapeutic or Preventive Procedure,intervention,Health Care Activity,ISA
16625528,title,1,Replacement arthroplasty,Therapeutic or Preventive Procedure,internal fixation,Therapeutic or Preventive Procedure,COMPARED_WITH
16625528,title,1,internal fixation,Therapeutic or Preventive Procedure,hip fractures,Injury or Poisoning,TREATS
16625528,title,1,hip fractures,Injury or Poisoning,adults,Age Group,PROCESS_OF
16625528,title,1,Replacement arthroplasty,Therapeutic or Preventive Procedure,hip fractures,Injury or Poisoning,TREATS
16625528,abstract,1,Internal fixation,Therapeutic or Preventive Procedure,hip fractures,Injury or Poisoning,TREATS
16625528,abstract,1,Internal fixation,Therapeutic or Preventive Procedure,unstable fractures,Injury or Poisoning,TREATS
16625528,abstract,5,hip fracture,Injury or Poisoning,adults,Human,PROCESS_OF
16625528,abstract,5,replacement arthroplasty,Therapeutic or Preventive Procedure,implant,Medical Device,COMPARED_WITH
16625528,abstract,5,internal fixation,Therapeutic or Preventive Procedure,implant,Medical Device,USES
16625528,abstract,5,replacement arthroplasty,Therapeutic or Preventive Procedure,adults,Human,TREATS
16625528,abstract,5,implant,Medical Device,adults,Human,TREATS
16625528,abstract,5,implant,Medical Device,hip fracture,Injury or Poisoning,TREATS
16625528,abstract,5,replacement arthroplasty,Therapeutic or Preventive Procedure,hip fracture,Injury or Poisoning,TREATS
16628891,abstract,5,sugar water consumption,Organic Chemical,pollination,Organism Function,AFFECTS
16628891,abstract,5,dead,Finding,adults,Human,PROCESS_OF
16628891,abstract,5,dead,Finding,larvae,Invertebrate,PROCESS_OF
16630952,abstract,2,Extrapulmonary tuberculosis,Disease or Syndrome,immunodeficiency,Disease or Syndrome,PREDISPOSES
16630952,abstract,3,immune defects,Pathologic Function,persons,Human,PROCESS_OF
16630952,abstract,3,extrapulmonary tuberculosis,Disease or Syndrome,persons,Human,PROCESS_OF
16641628,abstract,4,Treacher Collins,Congenital Abnormality,patients,Human,PROCESS_OF
16641628,abstract,4,standard reconstructive surgeries,Therapeutic or Preventive Procedure,customized parascapular free flaps,"Body Part, Organ, or Organ Component",PRECEDES
16641628,abstract,4,reconstructive surgeries,Therapeutic or Preventive Procedure,patients,Patient or Disabled Group,TREATS
16641628,abstract,4,reconstructive surgeries,Therapeutic or Preventive Procedure,Treacher Collins,Congenital Abnormality,TREATS
16641628,abstract,6,Treacher Collins syndrome,Congenital Abnormality,patients,Human,PROCESS_OF
16641628,abstract,6,microsurgical,Therapeutic or Preventive Procedure,patients,Human,ADMINISTERED_TO
16641628,abstract,6,microsurgical,Therapeutic or Preventive Procedure,free flaps,Tissue,USES
16643848,abstract,1,KCl,Pharmacologic Substance,differentiation,Cell Function,AUGMENTS
16643848,abstract,1,hST8Sia III,Gene or Genome,gene transcription,Genetic Function,LOCATION_OF
16643848,abstract,1,U-87MG cells,Cell,phosphoinositide 3 kinase (PI-3K),"Amino Acid, Peptide, or Protein",LOCATION_OF
16643848,abstract,1,neuronal cells,Cell,differentiation,Cell Function,LOCATION_OF
16643848,abstract,1,U-87MG cells,Cell,glioblastoma,Neoplastic Process,LOCATION_OF
16643848,abstract,1,KCl,Pharmacologic Substance,gene transcription,Genetic Function,AUGMENTS
16643848,abstract,1,KCl,Pharmacologic Substance,phosphoinositide 3 kinase (PI-3K),"Amino Acid, Peptide, or Protein",INTERACTS_WITH
16644456,abstract,6,small bowel,"Body Part, Organ, or Organ Component",lesions,Finding,LOCATION_OF
16644456,abstract,6,lesions,Finding,patients,Human,PROCESS_OF
16644456,abstract,6,arthritis,Disease or Syndrome,patients,Human,PROCESS_OF
16644456,abstract,6,nonsteroidal anti-inflammatory drugs,Pharmacologic Substance,patients,Human,ADMINISTERED_TO
16644456,abstract,6,lesions,Finding,subjects,Human,PROCESS_OF
16673312,abstract,8,intestinal tuberculosis,Disease or Syndrome,patients,Human,PROCESS_OF
16673312,abstract,8,Crohn's disease,Disease or Syndrome,patients,Human,PROCESS_OF
16687138,abstract,1,norepinephrine,Neuroreactive Substance or Biogenic Amine,neurotransmitter,Neuroreactive Substance or Biogenic Amine,ISA
16687138,abstract,1,cecum,"Body Part, Organ, or Organ Component",murine,Mammal,PART_OF
16687138,abstract,1,colon,"Body Part, Organ, or Organ Component",porcine,Mammal,PART_OF
16688036,abstract,2,kyphosis,Anatomical Abnormality,lordosis,Anatomical Abnormality,COEXISTS_WITH
16688036,abstract,2,kyphosis,Anatomical Abnormality,Scheuermann kyphosis,Disease or Syndrome,COEXISTS_WITH
16688036,abstract,2,lordosis,Anatomical Abnormality,Scheuermann kyphosis,Disease or Syndrome,COEXISTS_WITH
16689926,title,2,nicotinic acetylcholine receptor,Gene or Genome,Torpedo californica,Fish,PART_OF
16696376,abstract,3,azoospermia,Disease or Syndrome,patients,Human,PROCESS_OF
16696376,abstract,3,chromosomal alterations,Cell or Molecular Dysfunction,patients,Human,PROCESS_OF
16702302,abstract,5,weight loss,Finding,bone loss,Pathologic Function,COEXISTS_WITH
16702302,abstract,5,bone loss,Pathologic Function,Older populations,Human,OCCURS_IN
16702302,abstract,5,weight loss,Finding,Older populations,Human,OCCURS_IN
16702302,abstract,6,bone loss,Pathologic Function,weight loss,Finding,COEXISTS_WITH
16702302,abstract,6,hormonal,Hormone,bone loss,Pathologic Function,AFFECTS
16709260,abstract,9,proteins,"Amino Acid, Peptide, or Protein",fertilization,Organism Function,AFFECTS
16710995,abstract,4,rat,Neoplastic Process,glioma cells,Mammal,PROCESS_OF
16710995,abstract,4,cells,Cell,glioma,Neoplastic Process,LOCATION_OF
16710995,abstract,4,cells,Biologically Active Substance,plasmid,Cell,ADMINISTERED_TO
16719197,abstract,7,symptoms,Sign or Symptom,patients,Human,PROCESS_OF
16719197,abstract,7,symptoms,Sign or Symptom,hypercalcemia,Disease or Syndrome,MANIFESTATION_OF
16719197,abstract,8,signs,Sign or Symptom,patients,Human,PROCESS_OF
16719197,abstract,8,papillary carcinoma,Neoplastic Process,patients,Human,PROCESS_OF
16719197,abstract,8,thyroid,"Body Part, Organ, or Organ Component",papillary carcinoma,Neoplastic Process,LOCATION_OF
16719197,abstract,10,tumors,Neoplastic Process,patients,Human,PROCESS_OF
16719197,abstract,10,palpable masses,Finding,patients,Human,PROCESS_OF
16724072,abstract,2,systemic lupus erythematosus,Disease or Syndrome,patients,Human,PROCESS_OF
16732098,title,1,Parturition,Organism Function,rat,Mammal,PROCESS_OF
16732098,abstract,7,oxytocin,"Amino Acid, Peptide, or Protein",rats,Mammal,TREATS
16732098,abstract,7,morphine,Organic Chemical,rats,Mammal,TREATS
16732098,abstract,7,morphine,Organic Chemical,labor duration,Clinical Attribute,AFFECTS
16732098,abstract,7,lumbosacral spinal,"Body Part, Organ, or Organ Component",neurons,Cell,LOCATION_OF
16732098,abstract,7,neurons,Cell,c-Fos,Gene or Genome,LOCATION_OF
16732098,abstract,7,morphine,Organic Chemical,neurons,Cell,DISRUPTS
16732879,abstract,4,infections,Disease or Syndrome,puppies,Mammal,PROCESS_OF
16732879,abstract,4,moxidectin,Antibiotic,infections,Disease or Syndrome,PREVENTS
16733164,abstract,9,glass bead test,Laboratory Procedure,heparinase,"Amino Acid, Peptide, or Protein",USES
16733164,abstract,9,glass bead test,Laboratory Procedure,heparinase,"Amino Acid, Peptide, or Protein",USES
16733164,abstract,13,glass bead test,Laboratory Procedure,heparinase,"Amino Acid, Peptide, or Protein",USES
16733895,abstract,1,hydrogen sulfide,Inorganic Chemical,pulmonary vascular structure,"Body Part, Organ, or Organ Component",AFFECTS
16733895,abstract,1,hydrogen sulfide,Inorganic Chemical,peptides,"Amino Acid, Peptide, or Protein",INTERACTS_WITH
16733895,abstract,1,pulmonary vascular structure,"Body Part, Organ, or Organ Component",rats,Mammal,PART_OF
16733895,abstract,1,peptides,"Amino Acid, Peptide, or Protein",rats,Mammal,PART_OF
16733895,abstract,1,pulmonary hypertension,Disease or Syndrome,rats,Mammal,PROCESS_OF
16733895,abstract,1,blood flow,Organism Function,pulmonary hypertension,Disease or Syndrome,CAUSES
16733895,abstract,9,pulmonary arteries,"Body Part, Organ, or Organ Component",rats,Mammal,PART_OF
16736257,abstract,5,microtubules,Cell Component,blepharoplast,Cell Component,PART_OF
16736257,abstract,5,antibodies,"Amino Acid, Peptide, or Protein",acetylated tubulin,"Amino Acid, Peptide, or Protein",INTERACTS_WITH
16736257,abstract,6,core,Cell Component,blepharoplast,Cell Component,PART_OF
16736257,abstract,6,centrosome,Cell Component,antibodies,"Amino Acid, Peptide, or Protein",LOCATION_OF
16750542,abstract,1,adrenoleukodystrophy,Disease or Syndrome,peroxisomal disorder,Disease or Syndrome,ISA
16750542,abstract,1,tissue,Tissue,tetracosanoic acid,Lipid,LOCATION_OF
16750542,abstract,1,tissue,Tissue,hexacosanoic acid,Lipid,LOCATION_OF
16750542,abstract,1,hexacosanoic acid,Lipid,very long chain fatty acids (VLCFA),Lipid,ISA
16750542,abstract,1,tetracosanoic acid,Lipid,very long chain fatty acids (VLCFA),Lipid,ISA
16750542,abstract,2,disorder,Disease or Syndrome,patients,Human,AFFECTS
16750542,abstract,2,brain damage,Injury or Poisoning,X-ALD,Disease or Syndrome,COEXISTS_WITH
16750542,abstract,2,peripheral demyelination,Pathologic Function,patients,Human,PROCESS_OF
16750542,abstract,2,adrenal insufficiency,Disease or Syndrome,patients,Human,PROCESS_OF
16750542,abstract,8,X-ALD,Disease or Syndrome,patients,Human,PROCESS_OF
16750542,abstract,8,erythrocyte,Cell,patients,Human,PART_OF
16750542,abstract,8,erythrocyte,Cell,antioxidant enzyme activities,Molecular Function,LOCATION_OF
16751040,abstract,1,ophthalmic findings,Sign or Symptom,patients,Human,PROCESS_OF
16751040,abstract,1,Danon disease,Disease or Syndrome,patients,Human,PROCESS_OF
16751040,abstract,1,Danon disease,Disease or Syndrome,cardiomyopathy,Disease or Syndrome,CAUSES
16751040,abstract,1,cardiomyopathy,Disease or Syndrome,males,Human,PROCESS_OF
16751040,abstract,1,cardiomyopathy,Disease or Syndrome,females,Human,PROCESS_OF
16752564,abstract,11,Experiment,Research Activity,phantom,Medical Device,USES
16754935,abstract,1,diffuse large B-cell lymphoma,Neoplastic Process,patients,Human,PROCESS_OF
16754935,abstract,1,CHOP,Therapeutic or Preventive Procedure,R-CHOP,Therapeutic or Preventive Procedure,COMPARED_WITH
16754935,abstract,1,rituximab (MR),Pharmacologic Substance,patients,Human,TREATS
16757590,title,1,DNA,"Nucleic Acid, Nucleoside, or Nucleotide",human papillomavirus,Virus,PART_OF
16757590,abstract,4,DNA,"Nucleic Acid, Nucleoside, or Nucleotide",HPV,Virus,PART_OF
16763070,abstract,3,testis function,Organ or Tissue Function,rats,Mammal,PROCESS_OF
16763070,abstract,3,dibutyl phthalate,Organic Chemical,pregnancy maintenance,Organism Function,DISRUPTS
16763070,abstract,3,dibutyl phthalate,Organic Chemical,Long Evans (LE) hooded rats,Mammal,ADMINISTERED_TO
16763070,abstract,3,dibutyl phthalate,Organic Chemical,testis function,Organ or Tissue Function,AFFECTS
16763070,abstract,4,DBP,Pharmacologic Substance,LE rats,Mammal,ADMINISTERED_TO
16763070,abstract,4,DBP,Pharmacologic Substance,abortions,Finding,CAUSES
16763070,abstract,4,DBP,Pharmacologic Substance,abortions,Finding,CAUSES
16765853,title,1,Autogenic training,Therapeutic or Preventive Procedure,tension type headaches,Disease or Syndrome,TREATS
16765853,abstract,10,autogenic training,Therapeutic or Preventive Procedure,patients,Human,TREATS
16765853,abstract,10,headache,Sign or Symptom,patients,Human,PROCESS_OF
16765853,abstract,10,autogenic training,Therapeutic or Preventive Procedure,headache,Sign or Symptom,TREATS
16774846,abstract,12,seizures,Sign or Symptom,persons,Human,PROCESS_OF
16774846,abstract,12,calorie-restricted diets,Therapeutic or Preventive Procedure,persons,Human,TREATS
16774846,abstract,12,calorie-restricted diets,Therapeutic or Preventive Procedure,seizures,Sign or Symptom,TREATS
16781345,abstract,4,ACC,Neoplastic Process,patients,Human,PROCESS_OF
16781345,abstract,23,resection,Therapeutic or Preventive Procedure,radiotherapy,Therapeutic or Preventive Procedure,COEXISTS_WITH
16781345,abstract,23,resection,Therapeutic or Preventive Procedure,treatment,Therapeutic or Preventive Procedure,ISA
16781345,abstract,23,treatment,Therapeutic or Preventive Procedure,ACC,Neoplastic Process,TREATS
16781345,abstract,23,resection,Therapeutic or Preventive Procedure,ACC,Neoplastic Process,TREATS
16787352,abstract,2,1-butanol,Lipid,Straight chain alkanols,Organic Chemical,ISA
16787352,abstract,2,1-hexanol,Organic Chemical,Straight chain alkanols,Organic Chemical,ISA
16787352,abstract,2,1-pentanol,Organic Chemical,Straight chain alkanols,Organic Chemical,ISA
16798222,abstract,2,NF-kappaB,"Amino Acid, Peptide, or Protein",nonsmall-cell lung cancer,Neoplastic Process,ASSOCIATED_WITH
16798222,abstract,2,NSCLC,Neoplastic Process,patients,Human,PROCESS_OF
16798222,abstract,12,NF-kappaB,"Amino Acid, Peptide, or Protein",apoptosis,Cell Function,DISRUPTS
16798222,abstract,12,NSCLC,Neoplastic Process,patients,Human,PROCESS_OF
16801230,abstract,1,laboratory,Organization,experiment,Research Activity,LOCATION_OF
16809978,abstract,7,AN,Mental or Behavioral Dysfunction,patients,Human,PROCESS_OF
16809978,abstract,7,renal function deterioration,Finding,patients,Human,PROCESS_OF
16809978,abstract,7,renal function deterioration,Finding,AN,Mental or Behavioral Dysfunction,COEXISTS_WITH
16823322,abstract,1,choroid plexus,"Body Part, Organ, or Organ Component",vascular malformation,Congenital Abnormality,LOCATION_OF
16823322,abstract,1,cerebral aqueduct,Body Space or Junction,vascular malformation,Congenital Abnormality,LOCATION_OF
16823322,abstract,1,fourth ventricles,Body Space or Junction,vascular malformation,Congenital Abnormality,LOCATION_OF
16823322,abstract,1,"third, and fourth ventricles",Body Space or Junction,vascular malformation,Congenital Abnormality,LOCATION_OF
16823322,abstract,1,cerebral aqueduct,Body Space or Junction,adolescent female,Human,PART_OF
16823322,abstract,1,fourth ventricles,Body Space or Junction,adolescent female,Human,PART_OF
16823322,abstract,1,"third, and fourth ventricles",Body Space or Junction,adolescent female,Human,PART_OF
16823322,abstract,4,third ventricle,Body Space or Junction,mass,Finding,LOCATION_OF
16823322,abstract,4,cerebral aqueduct,Body Space or Junction,mass,Finding,LOCATION_OF
16823322,abstract,4,fourth ventricle,Body Space or Junction,mass,Finding,LOCATION_OF
16823322,abstract,4,magnetic resonance imaging scans,Diagnostic Procedure,mass,Finding,DIAGNOSES
16823322,abstract,4,magnetic resonance imaging scans,Diagnostic Procedure,contrast,"Indicator, Reagent, or Diagnostic Aid",USES
16823322,abstract,4,magnetic resonance imaging scans,Diagnostic Procedure,contrast,"Indicator, Reagent, or Diagnostic Aid",USES
16823322,abstract,8,Choroid plexus,"Body Part, Organ, or Organ Component",vascular malformations,Congenital Abnormality,LOCATION_OF
16823322,abstract,8,intraventricularly,Body Location or Region,vascular malformations,Congenital Abnormality,LOCATION_OF
16842506,abstract,7,intraepithelial,Spatial Concept,neutrophils,Cell,LOCATION_OF
16842506,abstract,7,neutrophils,Cell,inflammatory cells,Cell,ISA
16850791,abstract,1,disorders,Disease or Syndrome,patients,Human,PROCESS_OF
16856002,title,1,contraception,Therapeutic or Preventive Procedure,oral contraceptives,Pharmacologic Substance,USES
16856002,abstract,2,oral contraceptive pills,Pharmacologic Substance,breakthrough bleeding,Finding,AUGMENTS
16856002,abstract,20,norethindrone,Hormone,progestin,Hormone,ISA
16856443,abstract,3,fetal echocardiography,Diagnostic Procedure,pregnant women,Human,ADMINISTERED_TO
16856443,abstract,3,Siriraj Hospital,Health Care Related Organization,fetal echocardiography,Diagnostic Procedure,LOCATION_OF
16875036,abstract,1,Turner syndrome,Disease or Syndrome,women,Human,PROCESS_OF
16875036,abstract,1,ovulation,Organ or Tissue Function,Pregnancies,Organism Function,CAUSES
16875036,abstract,1,ovulation,Organism Function,Pregnancies,Organism Function,CAUSES
16875036,abstract,1,Pregnancies,Organism Function,women,Human,PROCESS_OF
16877310,title,1,cells,Cell,diminazene,Organic Chemical,LOCATION_OF
16877310,title,1,organs,"Body Part, Organ, or Organ Component",diminazene,Organic Chemical,LOCATION_OF
16877721,title,1,endostatin,"Amino Acid, Peptide, or Protein",human,Human,PART_OF
16877721,title,1,endostatin,"Amino Acid, Peptide, or Protein",patients,Human,TREATS
16877721,title,1,neuroendocrine tumors,Neoplastic Process,patients,Human,PROCESS_OF
16877721,title,1,endostatin,"Amino Acid, Peptide, or Protein",neuroendocrine tumors,Neoplastic Process,TREATS
16877721,abstract,4,pancreatic endocrine tumors,Neoplastic Process,patients,Human,PROCESS_OF
16877721,abstract,4,carcinoid tumors,Neoplastic Process,patients,Human,PROCESS_OF
16877721,abstract,4,rhEndostatin,Pharmacologic Substance,patients,Human,TREATS
16877721,abstract,4,rhEndostatin,Pharmacologic Substance,pancreatic endocrine tumors,Neoplastic Process,TREATS
16877721,abstract,4,rhEndostatin,Pharmacologic Substance,carcinoid tumors,Neoplastic Process,TREATS
16879324,abstract,1,melatonin,Hormone,blood-brain barrier,"Body Part, Organ, or Organ Component",AFFECTS
16879324,abstract,1,tissue plasminogen activator,"Amino Acid, Peptide, or Protein",hemorrhagic transformation,Disease or Syndrome,CAUSES
16879324,abstract,1,ischemic stroke,Disease or Syndrome,hemorrhagic transformation,Disease or Syndrome,PRECEDES
16879324,abstract,1,ischemic stroke,Disease or Syndrome,mice,Mammal,PROCESS_OF
16879324,abstract,1,melatonin,Hormone,blood-brain barrier,Organ or Tissue Function,AFFECTS
16879324,abstract,2,melatonin,Hormone,oxidative/nitrosative damage,Cell or Molecular Dysfunction,PREVENTS
16879324,abstract,2,melatonin,Hormone,permeability,Natural Phenomenon or Process,AUGMENTS
16879324,abstract,2,transient focal cerebral ischemia,Disease or Syndrome,mice,Mammal,PROCESS_OF
16887433,abstract,1,ghrelin,"Amino Acid, Peptide, or Protein",obesity,Disease or Syndrome,PREDISPOSES
16887433,abstract,1,obesity,Disease or Syndrome,Prader-Willi syndrome,Congenital Abnormality,COEXISTS_WITH
16887433,abstract,1,PWS,Congenital Abnormality,older persons,Human,PROCESS_OF
16887433,abstract,4,control groups,Human,ghrelin,"Amino Acid, Peptide, or Protein",LOCATION_OF
16887433,abstract,4,control groups,Human,ghrelin,"Amino Acid, Peptide, or Protein",LOCATION_OF
16887433,abstract,4,control groups,Human,insulin,"Amino Acid, Peptide, or Protein",LOCATION_OF
16887433,abstract,4,control groups,Human,glucose,Biologically Active Substance,LOCATION_OF
16887433,abstract,4,groups,Human,ghrelin,"Amino Acid, Peptide, or Protein",LOCATION_OF
16887433,abstract,4,groups,Human,ghrelin,"Amino Acid, Peptide, or Protein",LOCATION_OF
16887433,abstract,4,groups,Human,insulin,"Amino Acid, Peptide, or Protein",LOCATION_OF
16887433,abstract,4,groups,Human,glucose,Biologically Active Substance,LOCATION_OF
16887433,abstract,6,PWS,Congenital Abnormality,Children,Human,PART_OF
16887433,abstract,6,hyperphagia,Mental or Behavioral Dysfunction,Children,Human,PROCESS_OF
16887433,abstract,6,obesity,Disease or Syndrome,Children,Human,PROCESS_OF
16887433,abstract,6,ghrelin,"Amino Acid, Peptide, or Protein",Children,Human,PART_OF
16887433,abstract,6,PWS,Congenital Abnormality,people,Human,PART_OF
16887433,abstract,6,hyperphagic,Mental or Behavioral Dysfunction,people,Human,PROCESS_OF
16890392,abstract,2,cerebral hydatid cyst,Disease or Syndrome,children,Human,PROCESS_OF
16895685,abstract,1,renal arteries,"Body Part, Organ, or Organ Component",plaques,Finding,LOCATION_OF
16895685,abstract,1,Diffuse atherosclerosis,Disease or Syndrome,plaques,Finding,PREDISPOSES
16899102,abstract,2,beagle,Mammal,dogs,Mammal,ISA
16899102,abstract,2,ligature,Medical Device,Peri-implantitis,Disease or Syndrome,CAUSES
16899102,abstract,2,ligature placement,Medical Device,beagle dogs,Mammal,TREATS
16899102,abstract,2,ligature placement,Medical Device,beagle,Mammal,TREATS
16901783,title,1,Beta 4 integrin,Gene or Genome,ErbB2,Gene or Genome,STIMULATES
16901783,title,1,Beta 4 integrin,Gene or Genome,mammary tumorigenesis,Neoplastic Process,PREDISPOSES
16902165,abstract,3,chronic ischemic heart disease,Disease or Syndrome,patients,Human,PROCESS_OF
16902165,abstract,3,G-CSF,"Amino Acid, Peptide, or Protein",EPC,Cell,AFFECTS
16902165,abstract,3,EPC,Cell,patients,Human,PART_OF
16902165,abstract,4,CIHD,Disease or Syndrome,patients,Human,PROCESS_OF
16902165,abstract,4,injection,Therapeutic or Preventive Procedure,patients,Human,ADMINISTERED_TO
16902165,abstract,4,injection,Therapeutic or Preventive Procedure,G-CSF,"Amino Acid, Peptide, or Protein",USES
16902165,abstract,4,G-CSF,"Amino Acid, Peptide, or Protein",patients,Human,ADMINISTERED_TO
16903766,abstract,10,injection,Therapeutic or Preventive Procedure,BTX-A,Pharmacologic Substance,USES
16903766,abstract,10,injection,Therapeutic or Preventive Procedure,urinary,Disease or Syndrome,TREATS
16903766,abstract,10,injection,Therapeutic or Preventive Procedure,urinary incontinence,Disease or Syndrome,TREATS
16903766,abstract,10,overactive bladder,Disease or Syndrome,urinary incontinence,Disease or Syndrome,CAUSES
16903766,abstract,10,detrusor,"Body Part, Organ, or Organ Component",overactivity,Finding,LOCATION_OF
16903766,abstract,10,overactivity,Finding,urinary incontinence,Disease or Syndrome,CAUSES
16913431,abstract,11,pain behaviors,Individual Behavior,ethnic group,Human,PROCESS_OF
16913431,abstract,11,coping,Individual Behavior,ethnic group,Human,PROCESS_OF
16914119,title,1,"WIN 55,212",Organic Chemical,cannabinoid,Organic Chemical,ISA
16914119,title,1,"WIN 55,212",Organic Chemical,COX-2,"Amino Acid, Peptide, or Protein",STIMULATES
16914119,title,1,"WIN 55,212",Organic Chemical,PGE2,Hormone,STIMULATES
16914119,title,1,brain,"Body Part, Organ, or Organ Component",murine,Mammal,PART_OF
16914119,title,1,endothelial cells,Cell,COX-2,"Amino Acid, Peptide, or Protein",LOCATION_OF
16914119,title,1,endothelial cells,Cell,PGE2,Hormone,LOCATION_OF
16914119,abstract,2,MS,Disease or Syndrome,CNS inflammatory diseases,Disease or Syndrome,ISA
16914119,abstract,2,cyclooxygenase-2,"Amino Acid, Peptide, or Protein",endothelium,Tissue,PART_OF
16914119,abstract,2,endothelium,Tissue,brain,"Body Part, Organ, or Organ Component",PART_OF
16914119,abstract,2,TMEV,Virus,IDD,Disease or Syndrome,CAUSES
16914119,abstract,2,TMEV,Virus,infection,Disease or Syndrome,CAUSES
16914119,abstract,2,TMEV,Pathologic Function,IDD,Disease or Syndrome,CAUSES
16914119,abstract,2,cannabinoids,Organic Chemical,IDD,Disease or Syndrome,TREATS
16914119,abstract,2,cannabinoids,Organic Chemical,IDD,Disease or Syndrome,TREATS
16914119,abstract,2,cannabinoids,Organic Chemical,COX-2,"Amino Acid, Peptide, or Protein",INTERACTS_WITH
16914119,abstract,2,brain,"Body Part, Organ, or Organ Component",murine,Mammal,PART_OF
16914119,abstract,2,endothelial cell,Cell,brain,"Body Part, Organ, or Organ Component",PART_OF
16914119,abstract,2,cell cultures,Cell,endothelial,Tissue,PART_OF
16914119,abstract,6,infection,Disease or Syndrome,COX-2,"Amino Acid, Peptide, or Protein",PRODUCES
16914119,abstract,6,brain,"Body Part, Organ, or Organ Component",murine,Mammal,PART_OF
16914119,abstract,6,endothelial cell,Cell,brain,"Body Part, Organ, or Organ Component",PART_OF
16929605,abstract,8,laparotomic,Therapeutic or Preventive Procedure,incision,Therapeutic or Preventive Procedure,ISA
16950193,abstract,3,rheumatic mitral stenosis,Disease or Syndrome,patients,Human,PROCESS_OF
16950193,abstract,3,echocardiographically,Diagnostic Procedure,rheumatic mitral stenosis,Disease or Syndrome,DIAGNOSES
16950193,abstract,3,plasma,Body Substance,osteopontin,"Amino Acid, Peptide, or Protein",LOCATION_OF
16950193,abstract,3,patients,Human,osteopontin,"Amino Acid, Peptide, or Protein",LOCATION_OF
16950193,abstract,10,inflammation,Pathologic Function,patients,Human,PROCESS_OF
16979443,title,1,Selective Internal Radiation Therapy,Therapeutic or Preventive Procedure,liver metastases,Neoplastic Process,TREATS
16979443,title,1,colorectal adenocarcinoma,Neoplastic Process,liver metastases,Neoplastic Process,CAUSES
16979443,abstract,2,hepatocellular carcinoma,Neoplastic Process,malignancies,Neoplastic Process,ISA
16979443,abstract,2,liver metastases,Neoplastic Process,colorectal carcinoma,Neoplastic Process,COEXISTS_WITH
16979443,abstract,2,malignancies,Neoplastic Process,liver,"Body Part, Organ, or Organ Component",PART_OF
16979443,abstract,2,hepatocellular carcinoma,Neoplastic Process,liver,"Body Part, Organ, or Organ Component",PART_OF
16979443,abstract,2,malignancies,Neoplastic Process,neuroendocrine,Body System,PART_OF
16979443,abstract,6,nodules,Acquired Abnormality,tumor,Neoplastic Process,PART_OF
16986607,abstract,5,oviducal,"Body Part, Organ, or Organ Component",obstruction,Pathologic Function,LOCATION_OF
16986607,abstract,5,obstruction,Pathologic Function,mares,Mammal,PROCESS_OF
16986607,abstract,5,salpingitis,Disease or Syndrome,fibrous adhesions,Acquired Abnormality,CAUSES
16986607,abstract,5,oviducts,"Body Part, Organ, or Organ Component",mare,Mammal,PART_OF
16986607,abstract,5,mare's oviducts,"Body Part, Organ, or Organ Component",blockage,Finding,LOCATION_OF
17056862,abstract,14,head injuries,Injury or Poisoning,children,Age Group,PROCESS_OF
17131231,abstract,9,dystonia,Sign or Symptom,patients,Human,PROCESS_OF
17131231,abstract,9,Parkinson's disease,Disease or Syndrome,patients,Human,PROCESS_OF
17131231,abstract,9,dystonia,Sign or Symptom,Parkinson's disease,Disease or Syndrome,COEXISTS_WITH
17131231,abstract,9,surgical treatment,Therapeutic or Preventive Procedure,dystonia,Sign or Symptom,AFFECTS
17131231,abstract,9,oculomotor cranial nerves,"Body Part, Organ, or Organ Component",cranial,"Body Part, Organ, or Organ Component",PART_OF
17131231,abstract,9,oculomotor cranial nerves,"Body Part, Organ, or Organ Component",Dystonic reactions,Finding,LOCATION_OF
17131231,abstract,9,limbs,"Body Part, Organ, or Organ Component",Dystonic reactions,Finding,LOCATION_OF
17131231,abstract,9,Dystonic reactions,Finding,patients,Human,PROCESS_OF
17131231,abstract,9,operated,Therapeutic or Preventive Procedure,patients,Human,TREATS
17135279,abstract,9,DYRK1A,Gene or Genome,AD,Disease or Syndrome,ASSOCIATED_WITH
17135279,abstract,9,DYRK1A,Gene or Genome,tau,"Amino Acid, Peptide, or Protein",INTERACTS_WITH
17135279,abstract,9,DYRK1A,Gene or Genome,beta-amyloid,"Amino Acid, Peptide, or Protein",INTERACTS_WITH
17182661,abstract,1,Lobular neoplasia,Neoplastic Process,lesion,Finding,ISA
17182661,abstract,1,biopsy specimens,Tissue,Lobular neoplasia,Neoplastic Process,LOCATION_OF
17191304,title,1,toluene diisocyanate,Hazardous or Poisonous Substance,asthma,Disease or Syndrome,CAUSES
17191304,title,1,autoantibodies,"Amino Acid, Peptide, or Protein",asthma,Disease or Syndrome,PREDISPOSES
17293230,abstract,2,non-small-cell lung cancer,Neoplastic Process,patients,Human,PROCESS_OF
17293230,abstract,2,CT,Diagnostic Procedure,patients,Human,ADMINISTERED_TO
17293230,abstract,2,positron emission tomography,Diagnostic Procedure,patients,Human,ADMINISTERED_TO
17663001,title,1,invasive breast carcinoma,Neoplastic Process,patients,Human,PROCESS_OF
17663001,abstract,3,MMP-1,"Amino Acid, Peptide, or Protein",tissue specimens,Tissue,PART_OF
17663001,abstract,3,tissue specimens,Tissue,tumor,Neoplastic Process,PART_OF
17663001,abstract,3,tissue specimens,Tissue,patients,Human,PART_OF
17663001,abstract,3,breast carcinoma,Neoplastic Process,patients,Human,PROCESS_OF
17663001,abstract,3,tissue specimens,Tissue,mRNA expression,Genetic Function,LOCATION_OF
17663001,abstract,3,MMP-1,Genetic Function,mRNA expression,Enzyme,PRODUCES
